University of Connecticut

OpenCommons@UConn
Doctoral Dissertations

University of Connecticut Graduate School

4-24-2015

The Role of DYX1C1 in Motile Cilia and
Axonemal Dynein Assembly
Aarti Tarkar
University of Connecticut - Storrs, aarti.tarkar@uconn.edu

Follow this and additional works at: https://opencommons.uconn.edu/dissertations
Recommended Citation
Tarkar, Aarti, "The Role of DYX1C1 in Motile Cilia and Axonemal Dynein Assembly" (2015). Doctoral Dissertations. 694.
https://opencommons.uconn.edu/dissertations/694

The Role of DYX1C1 in Motile Cilia and Axonemal Dynein Assembly
Aarti Tarkar, Ph.D.
University of Connecticut, 2015
Motile cilia and flagella are essential to many biological functions that require
cellular or fluid movement. The motility of cilia and flagella in turn is dependent
upon the action of large protein complexes that serve as molecular motors. Such
axonemal motors are composed of multiple dyneins assembled in the cytoplasm
of cells with motile cilia. The mechanisms underlying this assembly are not fully
understood. Fortuitously, we found that genetic deletion of exons 2–4 of Dyx1c1
in mice caused a phenotype resembling Primary Ciliary Dyskinesia (PCD), a
disorder characterized by chronic airway disease, laterality defects and male
infertility. Ultrastructural and immunofluorescence analyses of Dyx1c1-mutant
motile cilia in mice showed disruptions of outer and inner dynein arms (ODAs
and IDAs, respectively). Dyx1c1 localizes to the cytoplasm of respiratory
epithelial cells. Its interactome is enriched for molecular chaperones, and it
interacts with the cytoplasmic axonemal motor assembly factor DNAAF2 (KTU)
as well as transition zone protein Septin2. Additionally, a missense mutation in
DYX1C1 found to lead to PCD in humans exhibits a weaker interaction of
DYX1C1 with Sept2 and KTU and has reduced activity in promoting association
of dyneins. These findings suggest that Dyx1c1 (DNAAF4) plays a role in dynein
arm assembly or trafficking and when mutated leads to primary ciliary dyskinesia
with laterality defects. Dyx1c1 interacts with intermediate and light chain subunits

of the dynein arm complex in the cytoplasm of tracheal epithelial cells. Light and
intermediate chains fail to form complexes in the cytoplasm of tracheal epithelial
cells of Dyx1c1 mutants. Dyx1c1 increases by four fold the association of light
chain subunits Dnal1 and Dnal4 in heterologously expressing HEK 293-T cells.
Finally, a missense mutation in Dyx1c1 (p.L19Q) which cause PCD in humans is
impaired in its ability to assembly Dnal1 and Dnal4. In conclusion, we identify a
step in axonemal dynein pre-assembly in which Dyx1c1 facilitates formation of
light and intermediate chain dynein complexes.
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1. INTRODUCTION
1.1 CILIA
1.1.1 History of the Cilium
Cilia are the oldest known organelles, the discovery of which dates back to over
three centuries. In September 1965, Anton Van Leeuwenhoeck, the father of
microscopy, used a simple mounted lens and first described the cilia as “thin feet
or little legs that moved very nimbly”. The term ‘cilia’ meaning eyelash, was
however coined in 1786 by O.F. Muller1. The ciliary motility was the first function
that was ever described. The most common organisms to study this motility
were ciliated protozoa, the clam gill, spermatozoa and the ciliated epithelia of
vertebrates. On June 28, 1978, Leeuwenhoeck wrote: “One can’t be satisfied
with just looking at so wonderful a structure, chiefly because one can’t get clear
on how such an unbelievable motion is brought about..”2; thus posing the
question: how do cilia work? Since then studies have focused on the biology of
the ciliary assembly and motility giving us insights about the function, categories
as well as ultrastructure of this organelle.
1.1.2 Cilia structure
Cilia and flagella are structures that project outward from the cell surface and
have important sensory and motile functions. They are composed of a
microtubule-based axoneme that is generated from a modified centriole called a
basal body. The axoneme is surrounded by a specialized plasma membrane that

	
  
is continuous with the plasma membrane of the cell body. At the distal end of the
basal body is the transition zone, where the triplet microtubule basal body
extends into the doublet microtubule axoneme. Transition fibers link the transition
zone of the centriole to a specialized region of the plasma membrane called the
“ciliary necklace”3. It has been proposed that this region acts similar to the
nuclear pore complexes of the nuclear envelope to selectively allow transport in
and out of the ciliary compartment (Fig 1-1).

Figure 1-1 Schematic of the ultrastructure of cilia. Cilia consist of a microtubular
scaffold that is connected to the cell via basal bodies. The region between the basal
bodies and the base of the microtubules is called the transition zone that functions as
trafficking region for the entry and exit of proteins. The apparatus is ensheathed in an
extension of the plasma membrane, known as the ciliary membrane.

All cilia are composed of a central microtubular scaffold, an intraflagellar
transport (IFT) system, and transmembrane proteins. The basal body, a root-like

	
  

2

	
  
structure comprised of microtubule triplets, acts as a template for the ciliary
ultrastructure. It is known that the basal bodies originate from the mitotic
centriole. In cells with a primary cilium, the mother centriole migrates to the
surface and, upon docking to the cell membrane, becomes known as the basal
body4,5. In multiciliated cells however, the centriole is thought to first differentiate
and multiply before their migration to the apical cell surface3,6-8. The mechanism
of this duplication of the centriole has recently spurred a lot of interest in ciliary
research.
1.1.3 Classification of cilia
The microtubules are arranged as nine outer doublets consisting of a complete
A-tubule and a fused incomplete B-tubule. These 9 doublets are connected to
each other via nexin links. In primary cilia, the central microtubules are arranged
as doublets in a 9+0 arrangement, whereas in motile cilia they are usually
arranged in a 9+2 arrangement9. However, there are some motile cilia where the
microtubules are in a 9+0 arrangement. Cilia are commonly grouped into two
broad classifications: motile and non-motile cilia10,11 (Fig 1-2).
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Figure 1-2 Classification of cilia: Cross-section of non-motile (9 + 0 arrangement) and
motile cilia (9 + 2 and 9 + 0 arrangement) is shown.

1.1.3.1 Motile Cilia

Motile cilia generally have a “9+2” structure, which refers to the nine doublet
microtubules and a central pair that make the axoneme. The nine outer doublets
are composed of A and B subfibers that are connected by nexin linkages. In
addition to the two central singlets, motile cilia also contain outer dynein arms
(ODA), inner dynein arms (IDA) and radial spokes along their length. The above
three structures are critical for the motility of the cilia. The movement occurs due
to the sliding of the microtubule doublets past each other in the presence of ATP.
The ODAs are known to be responsible for the ciliary beat generation while the
IDA and radial spokes regulate the beat waveform or pattern. Motility is conferred
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by the sliding of doublet microtubules relative to each other and this requires the
central pair microtubules, outer and inner dynein arms that project from the A
tubule and reversibly bind the neighboring B-tubule, and by radial spokes that
connect the A tubule of the outer doublet to the central pair12-14.

In mammals, motile cilia are found on cells of the airway epithelium, brain
ventricles, oviduct, sperm and embryonic node. Each of these, with the exception
of sperm and the ciliated cells of the embryonic node, possesses hundreds of
motile cilia, and their coordinated beating is vital for movement of fluid and
particles over the surface of the epithelium. In the node, motile cilia are unique in
that they lack a central pair (“9+0” motile cilia) but are able to rotate due to the
activity of ciliary dynein, and this movement generates nodal flow that it critical
for the establishment of left-right asymmetry15. The rotational motion allows the
cilia to move morphogens in developing tissue. Nodal cilia defects are associated
with left-right asymmetry and developmental defects16,17.

1.1.3.2 Non-motile cilia
The “9+0” primary cilium is distinct from the motile cilium in that it lacks a central
pair and the dynein arms required for ciliary motility, and only one is found per
cell. Primary cilia have been found on almost every cell in the human body with
the exception of the myeloid and lymphoid lineages. Once thought to be vestigial,
primary cilia are now known to be important for detecting chemical and
mechanical stimuli. Examples of specialized types of cilia are the olfactory
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receptor cilium, mechanosensing cilia in the kidney tubule epithelium and in
bone, and the connecting cilium of photoreceptor sensory neurons. In addition,
important developmental signaling pathways such as Sonic hedgehog, plateletderived growth factor receptor (PDGFR) alpha, polycystin and Wnt are
transduced through primary cilia. Kinocilia are microtubule-based ciliary
structures that contain a motile cilia-like ultrastructure but are not motile. These
cilia of the inner ear are thought to play a role in the planar cell polarity of the
stereocilia18.

1.1.4 Cilia formation and basal body generation
Vertebrate ciliogenesis was first described by electron microscopy (EM)
examination of ciliated tissues such as the multiciliated epithelia of rat airway
epithelium8. The early studies described ciliogenesis as proceeding in a series of
steps: 1) cytoplasmic generation of basal bodies, where they acquire
appendages required for basal body function, 2) basal body migration to the
surface of the cell, where vesicles fuse with the plasma membrane, allowing the
basal body to dock 3) and ciliary membrane growth and axoneme extension from
the basal body. How ciliary length is then maintained is not well characterized in
vertebrates, but in Chlamydomonas, this is achieved by balanced rates of
assembly and disassembly6,19,20.

Different pathways exist for the generation of basal bodies. In cells that make a
single cilium, the basal body derives from the mother centriole, which is
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duplicated according to the canonical centrosome cycle of dividing cells. In cells
that make multiple cilia, basal bodies are generated according to two
mechanisms: the canonical templated pathway and the acentrosomal nontemplated pathway. In the non-templated pathway, basal bodies arise de novo,
multiple basal bodies grow from an electron-dense mass termed the
deuterosome, which are present in multiples in the cytoplasm. In the template
pathway, a single centriole grows off the side of a pre-existing mother centriole in
the cytoplasm21,22. Another difference is that centriole duplication and maturation
occurs during G0 in multiciliated cells, which are terminally differentiated,
whereas in most cells in the body centrioles are duplicated once per cell cycle
and only in S-phase, and mature later in the cell cycle. Several studies have
identified that cilia are only observed in quiescent cells, or in cells that are in the
G0-G1 phase of the cell cycle. Furthermore, when the cell divides, the cilia must
be resorbed to free up the centriole for the mitotic spindle23-26. Post-division, the
centriole once again becomes a basal body, leading to ciliogenesis. The ability of
the cells to not undergo cell division in the presence of the cilium raises the
possibility of cilium as a cell division checkpoint organelle18.

1.1.5 Intraflagellar Transport
Protein synthesis does not occur inside the cilium, so components for cilia growth
and function are trafficked there. This is achieved by intraflagellar transport (IFT),
which was first identified in the unicellular flagellated algae Chlamydomonas
reinhardtii. IFT particles consist of “core” structural protein complexes, molecular
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motors and adaptor proteins, and there are two types of IFT: anterograde and
retrograde. In vertebrates, the anterograde IFT complex consists of IFT particles
B and the microtubule plus-end directed kinesin-II complex consisting of KIF3A,
KIF3B and KAP. Retrograde IFT complexes consist of IFT particles A and
cytoplasmic dynein 2. IFT complex B and A are composed of at least 10 and 6
proteins, respectively, and are thought to facilitate cargo transport through
interaction with protein binding domains

27

. Accumulations of IFT particles have

been detected at transition fibers, leading to the hypothesis that docking at the
transition zone might also be an important regulatory step for transport in and out
of the cilium 28-31.

1.2 MOTILITY OF CILIA

Within the ciliary axoneme, multi-protein complexes exist by interconnecting the
different components like the radial spokes, nexin links, central sheath and
dynein arms. The dynein arms are attached to the peripheral microtubules with
certain periodicity and are known to generate motility by ATP-dependent
mechanism. The dynein arms are large, multi-subunit complexes assembled with
polypeptides of different sizes: heavy chain (HC of 400-500 KDa), intermediate
chain (IC of 45-110 KDa) and light chains (LC of 8-55 KDa). The ATPase activity,
that provides the energy to produce the sliding movement between the
microtubules resulting in ciliary beating, resides in the HC molecules. The motility
of the dynein arms requires the orchestrated functioning of many dynein
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components32,33.
Studies have identified aberrant motility in Chlamydomonas strains. By
mutational analysis, a number of axonemal dyneins have been identified and
these studies indicate that 30-40 axonemal dyneins (14 HC, 7 IC and 15 LC)
combine to form the dynein arms. There are two general types of dyneins built
into motile axonemes: the outer-arm dyneins found towards the outside of the
axoneme, and inner-arm dyneins, which are positioned closest to the centralapparatus radial spokes12,14,32,34,35. The docking complex that attaches the outer
arm (ODA-DC) is composed of three polypeptides, whereas the one for the inner
arm has not yet been solved.
1.2.1 Outer Dynein Arms
Functional analysis has revealed that the outer arms provide about 80% of the
power generated during ciliary beating. Cilia that lack ODAs beat significantly
more slowly than wild type and thus defects in the outer arms are a major cause
of primary ciliary dyskinesia (PCD) in humans. In all organisms examined to date,
outer arms contain multiple either two (e.g. mammals and sea urchins) or three
(e.g. Chlamydomonas and Tetrahymena) HCs associated with two WD-repeat
ICs, a core set of LCs, and coiled-coil proteins involved in assembly within the
axoneme. Most of the homologous genes encoding axonemal polypeptides in
mammals have been identified. Furthermore, outer arms contain additional
components that act in various signaling pathways to control motor function.
Literature suggests that outer-arm dyneins contain a system that senses
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mechanical strain and allows the motors to compensate for increased load33,36.
ODA in eukaryotic cilia/flagella is a multimeric complex that is composed of
heavy chains (HCs) that contain ATPase/motor domains, intermediate chains
(ICs), and several light chains (LCs). The structure, subunit composition, and
regulation of ODA are best studied using the green alga Chlamydomonas
reinhardtii because numerous mutants with defects in the ODA subunit genes
have been isolated. In Chlamydomonas, three HCs are bound like a bouquet,
and two ICs and several LCs form a complex at the base of the bouquet (IC-LC
complex) (Fig. 1-3a). The exceptions are LC1, LC3, LC4, and LC5, which are
bound to either the motor domains or N- terminal regions of the HCs. The
composition of the ODA is shown in Fig. 1-3b.
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Figure 1-3: Composition of the outer dynein arm. (a) In mammals, the outer dynein
arm comprises of two heavy chains, two intermediate chains and about ten light
chains. (b) The individual outer dynein arm subunit composition. (Adapted from
Fliegauf et al. 2008)

ODAs are arranged linearly on specific sites of the A-tubule of doublet microtubules with a regular spacing of 24 nm, through interaction with the outer-dyneinarm docking complex (ODA-DC). The ODA-DC was first identified as a projection
on the ODA-lacking mutants in Chlamydomonas. Biochemical and genetic
analyses revealed that ODA-DC is composed of three subunits (termed DC1,
DC2, and DC3). The subunit composition of ODA-DC in other organisms is
different from that in Chlamydomonas. In humans, DC1 does not appear to be
conserved but two genes seem to be DC2 orthologs36-40.
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1.2.2 Inner Dynein Arms
In contrast to the outer dynein arm, which is homogeneous in composition and
organization; genetic, biochemical, and structural analysis in Chlamydomonas
have revealed seven major species of inner-arm dyneins: a, b, c, d, e, f (I1
dynein), and g, and at least three minor species of inner-arm dyneins: DHC3,
DHC4, and DHC11.
Based on genomic and structural analyses, the organization and complexity of
the inner dynein arms and 96 nm axonemal repeat was shown to be a highly
conserved feature of all motile axonemes36,41-44. The complete composition as
well as the predicted schematic of the IDA is presented in Fig. 1-4. Biochemical
studies have revealed that certain dyneins within the flagellum act as monomeric
motors and have a distinct complement of associated proteins including actin and
either an essential LC (termed p28 in Chlamydomonas) or the calcium-binding
calmodulin homolog centrin. Dimeric inner dynein arm contains two distinct HC
motors and plays a key role in the regulation of axonemal motility. Mutants that
lack this dynein exhibit slow swimming due to alterations in flagellar waveform
that result in a less efficient beat. There is one copy of the IDA located within
each 96 nm axonemal repeat and both HCs are necessary for its
assembly32,35,45,46.
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Figure 1-4: Schematic of the inner dynein arm and their subunit composition. Inner
dynein arm could consist of either one or two heavy chains, three or more
intermediate chains and three or more light chains. The detailed structure of the inner
dynein arms is not yet identified completely. The known subunit composition of the
inner dynein arms is shown in the bottom panel. (Adapted from Fliegauf et al. 2008)

1.2.3 Ciliary beat generation
The ODAs are responsible for the beat frequency and power required for
generation of normal axonemal motility, whereas the inner-arm dyneins regulate
the size and shape of the axonemal bend, parameters that are referred to as
“waveform”. The beat pattern of motile cilia consists of an effective stroke and a
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recovery stroke. The effective stroke is established when the cilia bend and move
in a vertical manner, and this movement is mediated by the ODA12,34,47. During
the recovery stroke, the cilia are found to travel in the horizontal direction
respective to the fluid flow. Thus, the motion of motile cilia results in a net
transport of particles in a single direction, a property that is essential especially
for the effective clearance of particulates from the airway.

As discussed briefly above, literature has revealed that the basis for ciliary
motility lies in controlled dynein-driven microtubule sliding-a "sliding microtubule"
model for ciliary bending (Fig. 1-5)

48-50

. In addition, it was determined that the

dynein motors generate force in one direction (minus-end direction) relative to
microtubule polarity48,51. Thus, since all dyneins are minus-end motors, this
observation directly led to a "switching" model for alternating effective
(principal/forward) and recovery (reverse) bending: dyneins on one side of a
structural and functional axis of the axoneme are active for bending in one
direction. When the direction of bending changes or "switches", there is a switch
in activity where the previously inactive dyneins, on one side of the axis, are
activated, and the formerly active dyneins on the opposite side, are turned off.
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Figure	
  1-‐5:	
  Sliding	
  model	
  of	
  microtubule	
  doublets. Bending of a cilium involves ATPdependent walking of motor domains of A-tubule dynein arms along adjacent B
tubules, toward the minus end. This causes the sliding of microtubule doublets. Minus
ends are anchored in the basal body, and flexible links between doublets (radial
spokes and nexin links) limit sliding. The result is bending of the cilium. (Adapted from
https://www.rpi.edu/dept/bcbp/molbiochem/MBWeb/mb2/part1/kinesin.htm)

The precise mechanism for sensing the end point of each bend direction is not
understood but clearly for oscillatory bending, dynein motors must be regulated.
Detailed experimental evidence indicates the basic oscillatory movement, and
"switches" in bend direction, are inherent properties of the dynein motors
involving microtubule curvature and a mechanical feedback control (Fig. 1-6)
50,52-54

	
  

. The switching sensor is not known, but one model includes the outer

15

	
  
dynein arm playing a role as a sensor of microtubule curvature53,55.

Figure	
  1-‐6:	
   Schematic	
  of	
   power	
  stroke. The power stroke of the motor protein, dynein,
attached to one microtubule, against subfiber B of a neighboring microtubule causes
the fibers to slide past each other. The flexible linker protein, nexin, converts the
sliding

motion

to

a

bending

motion.

(Adapted

from

http://www.arn.org/docs/behe/mb_mm92496.htm)

1.2.4 Molecular Pathways of Axonemal Dynein Assembly and Transport

Although axonemal dyneins function in cilia/flagella, these complex multicomponent enzymes are assembled in the cytoplasm and then transported into
the cilium. Initial evidence for this came from the analysis of the assembly state
of outer-arm dynein components in the cytoplasm of Chlamydomonas mutants
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defective for various dynein proteins and assembly factors. The assembly of the
outer-arm HCs and ICs with another HC was defective in the cytoplasm of strains
lacking either the intermediate chains or the HCs56. In contrast, the core motor
was completely assembled in the absence of the docking complex or ODA5
proteins57. Oda7 is a Leucine rich repeat (LRR) protein that resides in the cell
body and associates with both outer and inner arms. This protein possibly
functions as a linker that joins these two dyneins arms together and is
dissociated from the dynein complexes prior to their transport into the ciliary
axoneme58,59.
Additional cytoplasmic assembly factors for axonemal dyneins have recently
been described; both are members of the PIH group, which interact with heatshock family proteins. One protein encoded by the kintoun (ktu) gene was
identified in medaka following a mutant screen and also in humans with PCD. In
addition, the Chlamydomonas ortholog of Ktu, PF13 defects in which result in the
failure of both outer and inner dynein arm assembly. The Ktu/PF13 protein was
found to bind both dyneins and Hsp70, leading to the hypothesis that it acts as a
co-chaperone to aid dynein assembly in cytoplasm60,61. A second PIH protein
(MOT48) that is encoded at the IDA10 locus was identified as being required for
the assembly of a subset of monomeric inner dynein arms. Bioinformatics
analysis has identified additional PIH domain proteins in Chlamydomonas and
indicates that these PIH proteins are present only in organisms that bear motile
cilia. Furthermore, one of the uncharacterized Chlamydomonas PIH proteins
appears to be homologous to the TWISTER protein in zebrafish defects in which
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leads to polycystic kidneys and morphogenetic abnormalities61. An additional
protein ODA16 in Chlamydomonas was revealed that is required for transport of
outer-arm dyneins into the flagellum. This protein interacts directly with IFT46,
which is part of the IFT complex B and is thought to act essentially as a cargo
adaptor for outer-arm transport62.

1.3 CILIOPATHIES

Inherited human mutations that result in the broad disruption of cilia cause
severe developmental and adult phenotypes. Cilia are found on nearly every cell
of the human body and are diverse in form and function. Cilia function to clear
mucus, move fluid, to sense fluid flow and other mechanical forces, to intercept
extracellular signaling molecules and to concentrate and activate intracellular
signaling molecules. Cilia participate in developmental processes from breaking
the left-right symmetry of the embryo to tooth formation, and in adult processes
ranging from kidney tubule homeostasis to vision, olfaction, and hearing.
Mutations could affect a gene that disrupts an isolated cilia function and thus
cause a mild disease like retinal degeneration, or they could affect a gene
essential for all cilia functions and thus cause severe disease in all tissues where
cilia are found and result in embryonic lethality. Collectively, diseases or
developmental defects caused by an underlying defect in the assembly or
function of 9+2 or 9+0 cilia, or both, are termed ciliopathies11,63.
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1.3.1 Primary cilia-related ciliopathies

Of the 80 genes now linked to ciliary diseases, nearly three-quarters of them are
linked to cilia functions other than motility. Connecting cilia of retinal
photoreceptors are essential for vision. Rhodopsin, as well other proteins, are
produced in the inner segment of the photoreceptor and moved into the outer
segment via intraflagellar transport along the microtubules of the connecting
cilium. In the absence of this transport, photoreceptors die via apoptosis and the
retina degrades, resulting in progressive loss of vision. Retinitis Pigmentosa and
Leber Congenital Amaurosis are two types of retinal degeneration that have been
linked to mutations in gene products associated with the cilium. RPGR (retinitis
pigmentosa GTPase regulator) localizes to the connecting cilium of retina and
mutations in the gene encoding it account for 20% of all retinitis pigmentosa
cases. Interestingly, however, RPGR localizes to the transition zone of motile
cilia in the trachea, and mutations in RPGR have been identified in PCD64.

Autosomal dominant polycystic kidney disease (ADPKD), autosomal recessive
polycystic kidney disease (ARPKD), and nephronophthisis (NPHP) are
progressive cystic diseases of the kidney64-66. The genes mutated in ADPKD,
ARPKD, and NPHP localize to the primary cilia lining the tubules of the kidney,
where many cysts originate. This supports the hypothesis that cilia are involved
in these diseases. Positional cloning revealed that the gene Ift88 was mutated in
the Oak Ridge Polycystic Kidney disease mouse (Tg737orpk), a mouse model of
ARPKD67,68. Two gene products polycystin-1, and polycystin-2, encoded by Pkd1
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and Pkd2 respectively, are hypothesized to form a mechanosensory complex
that can sense the bending of primary cilia in response to the flow of fluid in
kidney tubules. The sensation of flow in the kidney tubule is required both for the
proper formation of tubules during development, and for the maintenance of
these tubules in adulthood. Mutation of Pkd1 or Pkd2 likely abolishes flow
sensation and causes a compensatory proliferation or rearrangement of tubular
cells. Mutation of Pkd1 or Pkd2 causes renal cystic disease due to the abolished
flow sensation causing a rearrangement of tubular cells. Interestingly, a few
genes, when mutated, can cause simultaneous cystic kidney disease and retinal
degeneration, a condition known as Senior Løken syndrome18,24,66,69,70.

Bardet-Biedl syndrome (BBS), Joubert syndrome (JS) and Meckel syndrome
(MKS) are all multisystem, complex, recessively inherited human diseases, which
display distinct but partially overlapping phenotypes. Common to these disorders
are ocular/retinal abnormalities, polydactyly, renal cystic disease, CNS
malformations or impairments, and situs inversus. Unique among these disorders
is cognitive impairments and obesity in BBS, cerebellar vermis hypoplasia in JS
and encephalocele and perinatal lethality in MKS. Genetically, there are
numerous commonalities between JS and MKS, yet very little overlap between
BBS and any other ciliopathy18,67,71-74.

1.3.2 Motile cilia-associated ciliopathies
Motile cilia play an important role during the development of, and in the
	
  

20

	
  
adulthood of, humans. The motile cilia of the node play a role in patterning the
left-right axis of vertebrates, and thus mutations that affect cilia in this structure
can result in situs inversus. Motile cilia with a 9+2 arrangement of microtubules
are found in the ependymal cells of the brain, epithelial cells of the trachea and
bronchioles, in sperm tails and throughout the female reproductive tract.

As

discussed above, primary cilia dyskinesia (PCD), also known as Kartagener’s
syndrome75, affects the motility of all cilia while leaving other functions intact.
Afzelius predicted that the gene mutated in his Kartagener patients might encode
the protein comprising the axonemal dynein arms that allow for the motility of cilia.
Nearly every gene variant linked to Kartagener’s syndrome since then has been
found to encode an axonemal dynein. However, recent studies have led to the
identification of other genes apart from axonemal dyneins that are known to
cause PCD76.

The diseases associated with defects in motile cilia tend to be more
straightforward due to the fact that motile cilia are primarily known for their role in
fluid movement. Ciliary beat frequency (CBF) is probably the best-studied aspect
of motile cilia biology, as defects in beating have numerous effects on human
health. It has been known that CBF can change in response to exogenous
signals. The many biological and chemical compounds that can affect CBF
include prostaglandin, extracellular ATP, cytokines, cigarette smoke, ethanol and
Vicks VapoRub77-81. Many neurotransmitters have been reported to modulate
CBF, although the pathways are complex since effects seem to differ between
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species. Recently it was found that motile cilia on mammalian airway epithelial
cells are also sites for G-protein coupled receptor proteins, and that motile cilia
alter their beating in response to exposure to bitter taste compounds82. Although
the functions ascribed to motile cilia and primary cilia have historically been
separate, this finding suggests that there may be more overlap than previously
thought.
1.3.3 Candidate PCD genes

Dynein arm defects account for 90% of PCD cases with defined ultrastructural
abnormalities. The newly discovered disease-causing gene mutations cause
functional defects but are not associated with a consistent ultrastructural defect.
Thus the presence of normal axonemal ultrastructure does not exclude PCD83. In
addition to the identification of cilia-related proteins, advances in techniques of
genetic screening and sequencing are leading the way for the use of genetic
testing as a diagnostic tool84. PCD, an autosomal recessive disorder, is highly
heterogenic owing to the large number of proteins involved in cilia assembly,
structure, and function. A growing number of genes that are involved in axonemal
motors, ciliary structure and regulation, or ciliary assembly and preassembly
have been implicated in PCD (Table 1-1).
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Table 1-1: Genes mutated in Primary Ciliary Dyskinesia (PCD). ODA: Outer
Dynein Arm, IDA: Inner Dynein Arm, HC: Heavy chain, IC: Intermediate chain, LC:
Light chain, CP: Central Pair, DRC: Dynein Regulatory Complex, and RSH: Radial
Spokes.
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The identification of PCD-associated genes has relied on a combination of
experimental models, proteomic analysis, and sequencing of candidate genes.
The best-studied model of motile cilia is the alga, C. reinhartii11,85. Screening
algae with defective motility or abnormal flagellar structure has been used to
study the function of orthologous ciliary proteins, which were linked to human
diseases. The second major advance leading to PCD gene identification was the
collection of ciliogenesis-related transcriptomes and cilia proteomes that provided
lists of cilia genes that could be linked to newly found disease mutations86-89.
More recently, parallel sequencing to analyze regions of interests in the genome
has allowed more rapid identification of multiple new mutations in cohorts of PCD
subjects without prior knowledge of candidate genes. In addition, whole-exome
sequencing has the potential to unravel the genetic causes of rare diseases and
was recently successfully used to identify new candidate genes associated with
PCD11,90.

To date, mutations in 19 different genes have been linked to PCD (Table 1-1),
and more candidates are being verified. Early searches for PCD-related
mutations identified genes that encode proteins integral to axonemal structure
and function; outer dynein arm: DNAH5, DNAI1, DNAL1, DNAI2, TXNDC3, and
DNAH1191-95; inner dynein arm and axonemal organization: CCDC39, CCDC40,
CCDC16496-99; central apparatus and radial spokes: RSPH9, RSPH4A, and
HYDIN100. More recently, mutations in several genes coding for several
cytoplasmic proteins not found in the axoneme have been linked to PCD. These
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proteins are presumed to have roles in cilia assembly or protein transport, and
mutations lead to ultrastructural abnormalities: HEATR2, DNAAF1, DNAAF2,
DNAAF3, CCDC103, LRRC6, and CCDC11460,101-106.

Most PCD-causing mutations have been identified in components of the ciliary
axoneme and mutations in two genes in particular, dynein axonemal intermediate
chain 1 (DNAI1; MIM 604366) and dynein axonemal heavy chain 5 (DNAH5; MIM
603335), which encode components of the outer dynein arm and account for
more than 30% of all cases. DNAI1 was the first disease-associated gene to be
identified using a candidate gene approach, by screening algae for abnormal
flagellar beat and outer dynein arm defects. DNAI1 mutations were found in a
large cohort at a prevalence of 9% of all identified PCD subjects. Mutations in
DNAH5, another component of the outer dynein arm, were discovered using
homozygosity mapping in large affected endogamous families, and later
identified by sequencing in PCD subjects. Other examples of mutated axonemal
proteins associated with PCD discovered using the candidate gene approach
include intermediate dynein chain DNAI2 (MIM 605483), which comprise about
2% of PCD patients, and TXNDC3 (MIM 607421). Mutations in the dynein
axonemal heavy chain 11 (DNAH11; MIM 603339) gene, which encodes an outer
dynein arm protein, are not associated with an ultrastructural defect and cilia
have normal (or more rapid) beat frequency. Mutations in other genes, such as
coiled-coil domain containing proteins CCDC39 (MIM 613798) and CCDC40
(MIM 613799), produce inconsistent ultrastructural abnormalities characterized
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by disordered microtubules in some but not all cilia.

Several nonstructural cilia-associated proteins have been found to be mutated in
PCD individuals and result in the absence of outer and inner dynein arms. These
mutations involve proteins that are considered to function in cilia assembly or
“preassembly” pathways. Identification of the involvement of these proteins has
spurred research into the mechanisms of cilia biogenesis. To understand the role
of these mutations, cilia biogenesis can be conceptually divided into the following
processes: intra-axonemal transport, transfer into the cilium, and cytoplasmic
preassembly. How specific proteins are coded for precise delivery and assembly
within the cilium and how the transition zone acts as a gate is not yet known.
1.3.3.1 PCD-causing preassembly proteins
Several gene mutations in preassembly proteins have been found to cause PCD.
The first PCD-associated preassembly protein found was DNAAF2 (MIM 613190),
which was identified in mutant zebrafish and later in PCD subjects who had
complete absence of outer dynein arms. Localized within the apical region of the
cell cytoplasm, DNAAF2 belongs to the proteins interacting with Hsp90 family
and interacts with DNAI2 and the chaperone heat shock protein HSP70 to
facilitate assembly or dynein complex transport into the cilia60,61. Similar to
DNAAF2, MOT48 is a protein interacting with Hsp90 localized in the cell body
that was identified in the Chlamydomonas to display motility defects and is
associated with preassembly of both outer dynein arms and a subset of inner
dynein arms, likely needed for the stability of dynein heavy chain components61.
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Mutations in the related proteins DNAAF1 (LRRC50; MIM 612517) and DNAAF3
(MIM 614566) caused outer dynein arm defects in subjects with PCD. Evidence
for assembly roles of these proteins is substantiated in mutant cells where
components of the inner dynein arm were found to accumulate in the cytoplasm
of mutated cells and fail to move into the cilium102,107. These findings indicate the
existence of a multistep cytoplasmic assembly pathway.

Another preassembly protein with mutations causative of PCD is HEATR2 (MIM
614864), which was recently implicated in dynein arm assembly. Similar to other
preassembly factors, HEATR2 is localized to the cytoplasm of ciliated cells rather
than in the apical region, which suggests that it either functions at different
stages of dynein assembly or is part of a chaperone complex that facilitates
transfer of different dynein complexes along an “assembly line.” The finding that
HEATR2 mutations are associated with mislocalization of inner arm proteins
supported this role101.

Mutations in LRRC6 (MIM 244400) also lead to PCD. A member of a protein
family with diverse functions, including splicing factors and nuclear transport,
LRRC6 is found in the cytoplasm and colocalizes with basal body markers.
Mutations in LRRC6 were shown to downregulate expression of other dynein arm
proteins and indicate an additional regulatory role108. Thus, dynein arm
preassembly is intricately regulated by both positive and negative feedback
mechanisms.
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1.4 DYX1C1
A candidate gene in DYX1, subsequently named DYX1C1, was first identified
through studies of a Finnish family in which a chromosomal rearrangement, a
translocation involving chromosomes 2 and 15, co-segregated with reading and
writing difficulties109-111. The chromosome 15 breakpoint of this translocation was
located within the DYX1 region that mapped to the DYX1C1 gene112.
1.4.1 DYX1C1 and Neuronal Migration

Wang and colleagues performed the first functional characterization of DYX1C1
where they utilized in utero knockdown of the rodent ortholog, Dyx1c1, of this
gene in the embryonic rat neocortex. This knockdown led to the abnormal
neuronal migration in the rat neocortex stalling the neurons in the intermediate
zone, thus leading to accumulation of neurons in the multipolar stage of
migration114,124,125. The effects of the knockdown were non-autonomous and also
disturbed some other neighboring cells in addition to the cells that had been
knocked down for Dyx1c1126. Overexpression of Dyx1c1 rescued migration,
confirming that the knockdown was causing the aberrant phenotype; and it was
found that the TPR domains were sufficient for this rescue 124.
1.4.2 DYX1C1 function and its known interactors

DYX1C1 is a 420 amino acid protein that is expressed ubiquitously in adult
tissues including brain. The protein can be detected by immunocytochemistry in
the nuclei and cytoplasm of neurons and glia in human neocortex. The protein
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domains of DYX1C1 include an N-terminal p23 and three C-terminal TPR
domains112. This combination of a p23 and TPR domains is shared with Sugtl, a
protein known to play a role in kinetochore assembly in yeast, suggesting a
potential role in cell division or cell dynamics. DYX1C1, when over-expressed in
cell lines, can interact with Hsp70, Hsp90 and an E-3 ubiquitin ligase, Chip,
suggesting that DYX1C1 may also be involved in the degradation of unfolded
proteins127,128. At its C-terminal, there are three tetratricopeptide domains (TPR)
which function in protein-protein interactions. Studies have shown that the rat
orthologue of DYX1C1 interacts with estrogen receptors in primary rat
neurons129. It has been thus proposed that DYX1C1 negatively regulates
estrogen receptor levels in a dose-dependent manner, decreasing their
transcriptional activity and stability. Variants in the promoter region of DYX1C1
have been suggested to mediate allele-specific binding of transcription factors
(such as TFII-I and Sp1) and/or to be associated with different expression levels
of the gene130.

Follow-up study on the function of Dyx1c1 demonstrated that when neurons were
subjected to embryonic knockdown of Dyx1c1 levels, they migrated past their
expected laminar targets114. These over-migration observations have been
confirmed in a subsequent investigation using live-cell imaging of human
neuroblastoma cells, where knockdown of DYX1C1 led to increased migration
rates compared with controls. This phenotype was dependent not only on the
TPR domains but also on another novel highly conserved motif, referred to as a
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DYX1 domain131. Analysis of changes in global gene expression levels after
perturbation of DYX1C1, by overexpression or knockdown in these cell lines,
uncovered a group of genes that was enriched for known functions, including
‘cellular

component

movement’,

‘cell

migration’,

and

‘nervous

system

development’, as well as a pathway involved in focal adhesion131,132. Tammimies
and colleagues specifically assessed whether DYX1C1 can interact with other
proteins implicated in neuronal migration and/or associated with dyslexia
susceptibility, including DCDC2 and KIAA0319. It was found that DYX1C1
interacts with LIS1 (a protein implicated in lissencephaly, a rare brain disorder
caused by severely disrupted neuronal migration) and DCDC2, but not with
KIAA0319. Several new interactions with DYX1C1 were also reported, with a
significant

overrepresentation

of

proteins

that

are

components

of

the

cytoskeleton, three of which (TUBB2B, TUBA1, and Ataxin1) were further
validated131.
1.4.3 DYX1C1 and ciliary function
The literature mining approach utilized by Ivliev and colleagues revealed that the
consensus ciliary signature included the dyslexia candidate genes DYX1C1,
DCDC2 and KIAA0319. This finding was however surprising since no role of cilia
has been identified to date in dyslexia121. Primary cilia are present on the surface
of neurons and hence cilia are implicated in early brain patterning and
homeostasis. As discussed earlier, a study has shown that overexpression of
DCDC2 in neurons changes the morphology and function of the primary cilium. In
sum, these studies raise a possibility that ciliary dysfunction might be associated
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with dyslexia.

Recent work by Chandrashekar and colleagues demonstrated the developmental
role of DYX1C1 using a zebrafish model. The zebrafish orthologue of DYX1C1 is
expressed in many ciliated tissues, and its knockdown leads to multiple
ciliopathy-related phenotypes such as body curvature, hydrocephalus, situs
inversus and kidney cysts. The dyx1c1 morphants also exhibited reduced cilia
length in several organs including Kupffer’s vesicle, pronephros, spinal canal and
olfactory placode. Furthermore, electron microscopic analysis of cilia in dyx1c1
morphants revealed loss of both outer (ODA) and inner dynein arms (IDA) that
have been shown to be required for cilia motility. In sum, an essential role for
dyx1c1 was proposed in cilia growth and function133.

1.5 Overview
Studies have been performed to evaluate the developmental role of Dyx1c1 in
the brain due to its association with dyslexia. However, further characterization of
the protein needs to be done to assess its role in development. A good approach
to characterize the function of Dyx1c1 protein is to generate a transgenic mouse
model that lacks the protein. The work herein highlights the role of Dyx1c1 in
mouse development and disease. In chapter 2, I show that the Dyx1c1 protein is
important for the function of motile cilia and the absence of Dyx1c1 leads to
ciliopathy phenotypes of hydrocephalus and situs inversus. It is thus
hypothesized to play a role in the assembly of the outer and inner dynein arms
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that are responsible for the motility of the cilia.

In chapter 3, I describe the localization and interactors (direct or indirect) of
Dyx1c1 in order to evaluate its role in the ciliary dynein assembly process. With
co-immunoprecipitation and mass spectrometric analysis, I found that Dyx1c1
interacts with heat shock proteins Hsp70, Hsp90 as well as T-complex
chaperones (CCTs). In addition to these proteins, an interesting interactor
Septin2 was identified that has been previously shown to be a protein of the
ciliary transition zone regulating the trafficking of proteins in and out of the cilium.
These findings strengthen the hypothesis that Dyx1c1, a protein that localizes to
the cytoplasm of ciliated cells, is required for the assembly and transport of the
axonemal dyneins.

In chapter 4, I describe a novel mutation that has been identified in Dyx1c1 that
is known to cause PCD in Druze patient population. Using western blot analysis
on the patients, I found that Dyx1c1 protein is expressed at the correct molecular
weight in these patients. The interactions of Dyx1c1 with Ktu and Septin2 are
reduced in the Dyx1c1 mutant condition, thus indicating a critical role of Dyx1c1
in the ciliary dynein assembly process.

In chapter 5, I identify the role of Dyx1c1 in the pre-assembly of axonemal
dyneins. By co-immunoprecipitation and western blot analysis, I show that
Dyx1c1 interacts with the outer dynein arm light chain subunits Dnal1 and Dnal4
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as well as intermediate chain subunits Dnai1 and Dnai2. However, in the
cytoplasm of the Dyx1c1 knockout tracheal epithelial cells, the interaction of
Dnal1 and Dnal4 is markedly reduced indicating a role of Dyx1c1 in the assembly
of these two proteins. Using a heterologous expression system, I show that
Dyx1c1 is essential for the association of Dnal1 and Dnal4; and this interaction
requires both the p23 and TPR domains of Dyx1c1.

In chapter 6, I provide a summary of the work performed in this thesis. I will
identify unanswered questions suggested by these works and propose follow up
studies to address them.
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2. CHARACTERIZATION OF THE DYX1C1 KNOCKOUT
MOUSE
2.1 Abstract
Dyx1c1 was the first gene associated with dyslexia susceptibility (Taipale et al
2003). While the results of RNAi experiments suggest a role in neuronal
migration (Wang et al 2006), and protein interaction studies suggest possible
roles in chaperonin function (Chen et al 2009) and estrogen receptor trafficking
(Massinen et al 2009), a genetic test for the required functions of Dyx1c1 has
been lacking. In order to elucidate the required functions of Dyx1c1, we have
analyzed the phenotype of a Dyx1c1 knockout mouse in which exons 2,3 and 4
were deleted. Western blot analysis confirmed that the mutation results in a
complete loss of Dyx1c1 protein expression. In breeding experiments between
heterozygous mice the ratio of homozygous KO, heterozygous, and WT mice
was 1:4:2, indicating possible embryonic lethality. The surviving Dyx1c1 knockout
mice display severe developmental abnormalities that include Situs Inversus, a
reversal in the typical left-right asymmetry of thoracic and abdominal organs and
early onset hydrocephaly. These two phenotypes are often associated with
Primary Ciliary Dyskinesia in mice. We therefore examined cilia structure and
motility in the ventricles of knockout mice. Immunostaining for acetylated tubulin,
and gamma tubulin indicated that the cilia of ependymal cells lining the lateral,
third, and fourth ventricles were intact and not appreciably decreased in number.
In contrast, live cell imaging and an Indian ink flow assay indicated a lack of
ciliary motility.
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observed in lateral, third and fourth ventricles using DIC video microscopy of
brain slices. However, in Dyx1c1 KOs cilia were completely immotile and
displayed no apparent beating. In an additional assay for the motility of cilia in
the lateral ventricles a small volume of Indian ink was applied to the surface of
the ventricle and the dispersion and flow of ink was imaged. In wt mice an
anteriorly directed flow was apparent with an approximate velocity of 96 mm/sec,
while in the KO mice the Indian ink showed only a passive diffusion in all
directions at a rate of 6 mm/sec. When the ultrastructure of the WT and KO cilia
was examined, we found that the inner and outer dynein arms that are required
for the ciliary motility were missing in the KO. In sum, the analysis of the Dyx1c1
KO thus indicates that Dyx1c1 is required for motility of cilia.

2.2 Introduction

Cilia, hair-like organelles projecting from the surface of nearly all polarized cell
types, serve essential roles in cellular signaling and motility. The basic structure
of motile cilia and the related organelle flagella is evolutionarily conserved. In
most motile cilia, a ring of nine peripheral microtubule doublets surrounds a
central pair apparatus of single microtubules that connect to the nine peripheral
doublets by radial spokes (9+2 structure). Motile monocilia present at the mouse
node during early embryogenesis are an exception, lacking the central pair
apparatus (9+0 structure)72,134. Distinct multi-protein dynein complexes attached
at regular intervals to the peripheral microtubule doublets contain molecular
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motors that drive and regulate ciliary motility. Specifically, ODAs are responsible
for beat generation, whereas both the IDAs and the nexin link–dynein regulatory
complexes (N-DRCs) regulate ciliary and flagellar beating pattern and frequency.
Identifying the proteins responsible for the correct assembly of this molecular
machinery is critical to understanding the causes of motile cilia–related
diseases134.
PCD (MIM 244400), a rare genetic disorder affecting approximately 1 in 20,000
individuals, is caused by immotile or dyskinetic cilia. Loss of ciliary function in
upper and lower airways causes defective mucociliary airway clearance and,
subsequently, chronic inflammation that regularly progresses to destructive
airway disease (bronchiectasis). Organ laterality defects are also observed, with
approximately half of individuals with PCD exhibiting situs inversus and, more
rarely, situs ambiguus, which can associate with complex congenital heart
disease. Dysfunctional sperm tails (flagella) frequently cause male infertility in
individuals with PCD. Another consequence of ciliary dysfunction, particularly
evident in mouse models, is hydrocephalus caused by disrupted flow of
cerebrospinal fluid through the cerebral aqueduct connecting the third and fourth
brain ventricles. Although ciliary dysmotility is not sufficient for hydrocephalus
formation in humans owing to morphological differences between the mouse and
human brains, the incidence of hydrocephalus, secondary to aqueduct closure, is
higher in individuals with PCD85,90,135.
Genetic analyses of individuals with PCD have identified several autosomal
recessive mutations in genes encoding axonemal subunits of the ODA
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complexes and related components. In addition, recessive mutations in
CCDC3996 (MIM 613798) and CCDC4097 (MIM 613799) have been linked to
PCD with severe tubular disorganization and defective nexin links. Mutations in
the radial spoke head genes RSPH4A and RSPH9 as well as in HYDIN can
cause intermittent or complete loss of the central-apparatus microtubules135. Two
X-linked PCD variants associated with syndromic cognitive dysfunction and
retinal degeneration are caused by mutations in OFD1 (MIM 311200) and RPGR
(MIM 312610), respectively. Another functional class of proteins emerging from
the identification of PCD-causing mutations are proteins involved in the
cytoplasmic preassembly of both ODAs and IDAs, including those encoded by
DNAAF260 (also known as KTU; MIM 612517), DNAAF1104 (also known as
LRRC50; MIM 613190), DNAAF3102 (also known as C19orf51; MIM 614566) and
the recently identified LRRC6103 (MIM 614930).
DYX1C1 (MIM 608706) was initially identified as a candidate dyslexia gene,
owing to both a single balanced translocation t(2;15)(q11;q21) coincidentally
segregating with dyslexia in a family and subsequent SNP association studies112.
Follow-up gene association studies have provided both positive and negative
support for association with dyslexia. Taipale et al. (2003) showed that DYX1C1
is expressed nearly ubiquitously in adult tissues, including brain, and that the
protein can be detected by immunocytochemistry in the nuclei and cytoplasm of
neurons and glia in human neocortex. The protein domains of DYX1C1 include
an N-terminal p23 and three C-terminal TPR domains. DYX1C1, when overexpressed in cell lines, can interact with Hsp70, Hsp90 and an E-3 ubiquitin
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ligase, CHIP, suggesting that the protein may also be involved in the degradation
of unfolded proteins127,128. Wang and colleagues performed the characterization
of the developmental function of DYX1C1 by employing in utero RNAi in
embryonic rat neocortex. The results from this study indicate that DYX1C1 plays
a role in the migration of neocortical neurons and more specifically is required for
the transition out of the multipolar stage of migration. Dyx1c1 RNAi decreased
the migration of neurons causing them to accumulate in a multipolar stage of
migration. The impairment was rescued by overexpression of Dyx1c1, and the Cterminal TPR domains were sufficient to rescue migration. Using truncation
mutants, they found that the C-terminus of DYX1C1 biases the cellular
localization of DYX1C1 to the cytoplasm, while the N-terminus alone can localize
to the nucleus and cytoplasm in cell lines and in developing neurons124,125.
Molecular and cellular analyses of DYX1C1 have indicated potential functional
roles in estrogen receptor trafficking, and recent proteomic and gene expression
studies have suggested a possible role in cilia121,129,133.

2.3 RESULTS
2.3.1 Generation of Dyx1c1-mutant mice
To elucidate the biological functions of DYX1C1, we performed a forward genetic
experiment by producing an allele of Dyx1c1 in mice in which exons 2–4 were
deleted (Fig. 2-1a). Homozygous mutant mice (Dyx1c1∆/∆) expressed no
detectable DYX1C1 protein by immunoblot analysis of all tissues tested,
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including brain and lung (Fig. 2-2b).

Figure 2-1: Targeted Deletion of Dyx1c1 (a) Schematic of the strategy for
producing the Dyx1c1 exon 2–4 deleted allele. A conditional knockout allele was
inserted by homologous recombination and then exons 2–4 were deleted from the
germline by breeding mice to an Hprt-Cre line of mice. (b) Left panel, PCR indicating
the genotyping results from the wild-type (F1/R1, 437bp) and deleted alleles (F1/R2,
356bp). Right panels, Western blots show the presence of Dyx1c1 protein detected in
brain and lung of wild-type (Dyx1c1+/+), and heterozygous animals (Dyx1c1Δ/+), but
missing from homozygous mutants (Dyx1c1Δ/Δ).

Mice heterozygous for the deletion allele were viable, fertile and not noticeably
different from wild-type littermates. Homozygous mutant mice were recovered
after birth from heterozygous breeding pairs at a rate deviating from the expected
Mendelian ratio (295:570:87 for Dyx1c1+/+:Dyx1c1 ∆/+:Dyx1c1∆/∆, c = 128.017,
P < 0.0001) but were recovered at early embryonic times (embryonic day (E)
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6.5–12) at the expected Mendelian ratio (22:43:20, c = 0.105, P = 0.85),
suggesting embryonic lethality of approximately two-thirds of homozygous
mutants (Fig. 2-2).

Figure 2-2 Recovery rates of the Dyx1c1 animals at embryonic and postnatal
timepoints. Graph shows the percentage survival of the wildtype, heterozygous and
knockout animals.

Homozygous mutants that survived after birth developed severe hydrocephalus
by postnatal day (P) 16 (Fig. 2-3) and died by P21, similar to what has been
described for other mouse mutants with defective motile cilia3,39.
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Figure 2-3: Dyx1c1 knockout mice exhibit hydrocephalus. Characteristic domed
crown in Dyx1c1Δ/Δ mice develops by P16 with the ventricles seen in coronal sections
are greatly expanded in Dyx1c1Δ/Δ relative to Dyx1c1+/+ mice. Scale bar, 250mm.

In addition to hydrocephaly, postnatal homozygous mutant mice displayed
laterality defects, with 59% of mutants (51/87) showing situs inversus totalis (a
complete inversion of left-right asymmetry; Fig. 2-4), 17% (15/87) showing situs
ambiguous with inverted heart and lung position relative to stomach and spleen
or inverted stomach and spleen position relative to heart and lung, and 24%
(21/87) showing situs solitus (normal left-right asymmetry).
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Figure 2-4: Dyx1c1 knockout mice exhibits situs inversus. (a) Situs inversus in
Dyx1c1Δ/Δ mice as seen in both the reversal of the milk filled stomach in neonates to
the right side, and exposed viscera showing reversal of multiple organs including
heart (He), stomach (St), and spleen (Sp). (b) Graph shows the organ symmetry of
the knockout mice.
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Mutations that cause disruptions in left-right asymmetry in mice40 are known to
result from defects in the function of motile nodal monocilia and, more specifically,
the

loss

of

cilia-generated

leftward

flow

across

the

node

in

early

embryogenesis40. The typical phenotype for laterality mutants is a 1:1 ratio of
situs inversus totalis and situs solitus, indicating a randomization of left-right
patterning, although the inv mutant mouse has 100% of affected pups with situs
inversus. Even if the ratio of situs inversus to situs solitus seen in surviving
Dyx1c1-mutant mice deviates significantly from what would be expected for a 1:1
ratio of situs inversus to situs solitus (51:21, c = 12.5, P = 0.0004), this ratio was
already observed in other mutants for left-right patterning, such as in Dnahc5mutant mice41.

2.3.2 Analysis of the nodal monocilia
Consistent with a role for DYX1C1 function in the embryonic node where left-right
patterning is established in the mouse, it has been found by whole-mount in situ
hybridization that Dyx1c1 expression in the early embryo (E7.5) was restricted to
pit cells of the embryonic node. Recently, it was shown that knockdown of
dyx1c1 results in phenotypes characteristically associated with cilia defects, such
as body curvature, hydrocephalus, cystic kidneys and situs inversus42. In
zebrafish, dyx1c1 is expressed in embryonic tissues that contain motile cilia42,
including Kupffer’s vesicle, which is known to have an important role in
establishing the left-right axis. We investigated the mutant mouse embryo at E7.5
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and found no striking structural abnormalities compared to the wildtype embryo.
However when we assessed the mutant mouse node, we found that some
vesicle like structures were present on the node in addition to the monocilia (Fig
2-5). In contrast, the wildtype node did not show the presence of any vesicle like
structures. The defective mouse node in the mutant could be due to the
dysmotile cilia that cause aberrant flow of the extra-embryonic fluid containing
morphogens required for the break of left-right asymmetry.
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Figure 2-5 Dyx1c1 knockout mouse node is abnormal. Top panel (a)
shows the wildtype E7.5 mouse embryo (left panel) and mouse node (middle,
right panel). Bottom panel (b) shows the knockout E7.5 mouse embryo (left
panel) and mouse node (middle, right panel). Blue arrows point to the node;
red arrows point to the cilia; and yellow arrows point to vesicle-like
depositions.
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2.3.3 Analysis of ependymal cilia
Hydrocephalus and organ laterality defects are hallmarks of mutations that cause
defects in ciliary motility in mice1,3. We therefore used light and electron
microscopy as well as video-microscopy to determine whether DYX1C1
deficiency caused loss of motile cilia formation or loss of cilia. Cilia extending
from mouse ependymal cells of the cerebral ventricles, visualized by light
microscopy, appeared similar in length and distribution in Dyx1c1∆/∆ and wildtype littermates (Fig. 2-6a). When immunofluorescence analysis on the was
performed to look for the any abnormalities of the lateral ventricles; we found that
markers for cilia (acetylated tubulin), cell margins (beta catenin) and basal bodies
(gamma tubulin) were present on lateral ventricles of Dyx1c1∆/∆ and wild-type
littermates without any significant differences in structure (Fig 2-6b).
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Figure 2-6 Cilia are present on the brain ependymal surface of the Dyx1c1
knockout mice. (a) H&E stained sections of the cerebral ventricles show the
presence of cilia on the surface of the ependymal cells in both Dyx1c1+/+ and
Dyx1c1Δ/Δ mice. (b) Immunofluorescence analyses of lateral ventricles stained for
acetylated tubulin (green), and beta-catenin and gamma tubulin (red).
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We used live-cell imaging to directly assess cilia-mediated fluid flow and ciliary
motility on the ependymal surface in Dyx1c1∆/∆ mice. We prepared explants or
slices of the lateral ventricular surfaces from Dyx1c1∆/∆ and wild-type mice at P6.
Ependymal cilia in wild-type mice continued to beat vigorously in these
preparations and created a directional fluid flow across the surface that could be
visualized by the displacement of a small volume of India ink pressure-injected
onto the ependymal surface. This flow was present in all wild-type mice tested (n
= 6; Fig. 2-7a) but was completely absent in tissue obtained from all Dyx1c1∆/∆
mice tested (n = 4; Fig. 2-7b).
We next examined the motility of ependymal cilia in coronal brain slices of wildtype and Dyx1c1∆/∆ mice by infrared differential interference contrast (DIC)
videomicroscopy. Cilia at the ependymal surface in wild-type and heterozygous
mice (n = 8) were found to beat at a frequency of approximately 9 beats/s (34 °C),
whereas cilia on ependymal cells from all Dyx1c1∆/∆ examined (n = 4) lacked
ciliary beating (Fig. 2-7b).
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Figure 2-7: Motile cilia of the Dyx1c1 knockout mice are dysfunctional. (a) Flow
of fluid (Indian ink) across the ependymal surface in brain ventricle cup preparations
from a Dyx1c1+/+ and Dyx1c1Δ/Δ at mice P6. Directional flow was rapid across the
surface of Dyx1c1+/+ ependymal epithelia, while only non-directional passive diffusion
was observed on ependymal surfaces in Dyx1c1Δ/Δ. The starting point for the fluid is
at the end of the pipette tip, seen bottom right. (b) Snapshots of the cilia motility in
wildtype (top panel) and knockout (bottom panel). The right panel shows the
displacement of the cilia.
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2.3.4 Analysis of Dyx1c1-mutant respiratory cilia
To assess the ultrastructure of respiratory cilia in mutants, we obtained
transmission electron micrographs of tracheal cilia. As on the ependymal surface,
tracheal cilia were abundant in both wild-type and Dyx1c1∆/∆ epithelial cells (Fig.
2-8a), but, unlike tracheal cilia in wild- type mice, cilia in the Dyx1c1∆/∆ trachea
were surrounded by cellular debris and mucus (Fig. 2-8a). We further examined
the ultrastructure of tracheal cilia in cross-sections by transmission electron
microscopy (TEM). Using TEM, we observed that tracheal and brain ependymal
cilia in wild-type and mutant mice had typical 9+2 microtubular structure with
intact radial spokes (Fig. 2-8b). In contrast, cilia in Dyx1c1∆/∆ mice lacked both
ODA and IDA structures in respiratory cilia (Fig. 2-8b). Thus, the phenotype
caused by loss of function of Dyx1c1 is a severe ciliary motility defect associated
with absent axonemal ODA and IDA structures.
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Figure 2-8: Dyx1c1 knockout motile cilia lack outer and inner dynein arms. (a)
TEM images of cross-sections through the trachea of wild-type and Dyx1c1Δ/Δ.
Abundant cilia were present in each, but cilia structures (red arrows) in the Dyx1c1Δ/Δ
trachea are surrounded by cellular debris and mucus. (b) TEM cross-section images
of ependymal and tracheal cilia in Dyx1c1+/+ and Dyx1c1Δ/Δ mice. The 9+2
microtubular structure was well preserved in Dyx1c1Δ/Δ, except that the outer and
inner dynein arms were lacking in tracheal cilia. The scale bars represent in (a) 1µm
(left panel) and 2µm (right panel) and in (b) 0.1 µm.

2.4 Discussion
Dyx1c1 was previously identified as a candidate dyslexia susceptibility gene that
plays an important role in the neuronal migration124. Studies performed to
characterize the molecular function of Dyx1c1 in zebrafish showed that Dyx1c1
has a role in ciliary function133. Here we explore the role of Dyx1c1 during
development, for which we generated a transgenic mouse wherein the exons 2,3
and 4 of the Dyx1c1 gene are deleted. The Dyx1c1 knockout mouse thus
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generated was verified by genotyping to confirm the deletion of the exons 2,3
and 4. We further performed western blot analysis on the protein lysates
obtained from the brain and lung tissues of the Dyx1c1 wildtype, heterozygous
and knockout mice. We observed that the Dyx1c1 protein was detected at the
molecular weight of 48KDa in the WT as well as heterozygous animals, however
the KO mice lacked the expression of Dyx1c1. The KO mice were found to die
perinatally, while those that survived after birth exhibited a deviation from the
expected Mendelian ratio (3:6:1 for WT:HET:KO) but were recovered at
embryonic times at the expected Mendelian ratio of (1:2:1 for WT:HET:KO).
Interestingly, the surviving KO mice exhibited two PCD-like phenotypes of
hydrocephalus and situs inversus. 59% of the mutant mice display situs inversus
totalis, 17% show situs ambiguous while 24% are situs solitus. The laterality
defects are known to result from the defects in the structure or function of motile
nodal monocilia especially due to the loss of the extra-embryonic nodal flow
proposed to carry morphogens responsible for the break of left-right asymmetry
patterning. When the E7.5 embryonic mouse node of the Dyx1c1 WT and KO
mouse was examined, we found that monocilia were present on the surface of
the epithelial cells of the node in both the conditions; however the KO displayed a
deposition of vesicle-like structures on the nodal surface indicative of a faulty
nodal flow and abnormal ciliary function.
The KO mice also developed severe hydrocephalus by P16 as evident from the
thinning of the cortex and enlarged ventricles; these animals die by P21.
Hydrocephalus could develop due to one or many of the following causes: i)
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absence of cilia on the ependymal cells of the brain, ii) cilia are present but they
are immotile, iii) abnormal production of the CSF, and iv) aqueductal stenosis. In
order to understand the cause of hydrocephalus in the KO mice, we investigated
whether the cilia were present on the ependymal cells of the ventricles and found
by immunofluorescence analysis that tufts of cilia were present on the KO
ependymal cells. However, live cell imaging and Indian ink assays showed that
the KO ependymal cilia were non-motile. This phenotype of immotile cilia was
consistent with the cilia of the tracheal epithelial cells of the KO, where we found
an accumulation of mucus or debris on the surface of the cilia.
Motile cilia defects are observed most commonly due to the defects in the ciliary
ultrastructure components such as the outer and inner dynein arms, radial
spokes or nexin links76. Transmission electron microscopy performed on the KO
ependymal and tracheal cilia revealed an absence of both the outer and inner
dynein arms that are known to be critical for ciliary motility.
In summary, we show that the Dyx1c1 knockout mice exhibit PCD-like
phenotypes, which resulted in axonemal defects of the dynein arms and ciliary
dysmotility. The association between Dyx1c1 and PCD-like phenotypes was also
recently reported in zebrafish, thus confirming the importance of Dyx1c1 in cilia
structure and function133,136,137. Further studies are required to characterize the
localization of the protein in ciliated cells in order to understand its role in ciliary
motility. Also, identification of the interactor partners of Dyx1c1 would shed light
on the functional pathway. Mutations in genes that are either axonemal dynein
subunits of the ODA or IDA have been previously identified that cause PCD in
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humans. Additionally, mutations in genes that are known to preassemble the
outer and inner dynein arms in the cytoplasm, like DNAAF1, DNAAF2, and
DNAAF3, or their transport to the basal bodies, similar to ODA16 have also been
defined that are known to cause PCD102,104,138,139. Thus, Dyx1c1 can be added to
the rapidly growing list of genes that when mutated cause PCD. Our data now
suggest that Dyx1c1 is a novel dynein axonemal assembly factor Dnaaf4.

2.5 Methods
2.5.1 Gene targeting and genotyping of Dyx1c1Δ/Δ mice.
Mice carrying the loxP– exon 2–4–loxP conditional allele of Dyx1c1 (Dyx1c1flox2–
4

) were generated by the University of Connecticut Health Center Gene Targeting

and Transgenic Facility. Embryonic stem cells harboring a loxP-flanked allele of
exons 2–4 of Dyx1c1 were produced by electroporating mouse embryonic stem
(ES) cells (129S6) with a targeting construct designed to replace exons 2–4 and
flanking intronic sequence through homologous recombination. We screened 96
ES cell clones by PCR for correctly targeted colonies. A single positive colony
was expanded and used for embryo reaggregation to produce five chimeric mice.
Three of these mice were shown to transmit the targeted allele through the germ
line to offspring in a cross with C57BL/6J mice. The PGK-Neo cassette in the
targeting

construct

was

then

removed

by

crossing

these

mice

with

129S4/SvJaeSor-Gt(ROSA)26Sortm1(FLP1)Dym/J mice (The Jackson Laboratory).
These offspring were used to generate a colony of Dyx1c1flox2–4/flox2–4 mice. To
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generate Dyx1c1del2–4/del2–4 (Dyx1c1Δ/Δ) mice with a deletion of exons 2–4, we
crossed

Dyx1c1flox2–4/flox2–4

mice

with

hypoxanthine-guanine

phosphoribosyltransferase (Hprt)-cre mice, C57B6/6-Hprttm1(cre)Mnn/J (University
of Connecticut Health Center). Genotyping was subsequently performed by PCR
using two pairs of primers (Fig. 1a and Supplementary Table 4). Animal
procedures were performed under protocols approved by the Institutional Animal
Care and Use Committee of the University of Connecticut and conform to US
NIH guidelines.

2.5.2 Immunohistochemistry of mouse tissue.
Mice

were

perfused

transcardially

with

0.9%

saline

followed

by

4%

paraformaldehyde (Electron Microscopy Science) in 1× PBS. Brains were
removed, fixed overnight in the same fixative at 4 °C and washed in 1× PBS
three times for 40 min the next day before cutting into 50-µm sections with a
vibratome (VT-1000S, Leica). Nuclei were counterstained with Hoechst 33342 (2
µg/ml in PBS; Sigma). Stained sections were washed for 10 min in PBS,
coverslips were applied using Prolong Gold Antifade (Invitrogen), and images
were acquired on a Carl Zeiss Axiovert 200M inverted microscope with an
ApoTome attachment and Axiovision 4.6 software (Carl Zeiss). Whole mounts of
the entire lateral wall of the lateral ventricles were prepared as described
previously48, fixed overnight in 4% paraformaldehyde in PBS at 4 °C and washed
in 1× PBS three times for 40 min the next day. They were then permeabilized
with 0.1% Triton X-100 (Sigma) in PBS for 10 min, blocked in 10% goat serum
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(Invitrogen) in PBS and 0.1% Triton X-100 for 1 h, and incubated with the
following primary antibodies: mouse antibody to acetylated tubulin (1:500 dilution;
Sigma, T6793), rabbit antibody to β-catenin (1:100 dilution; Cell Signaling
Technology, 9562) and mouse antibody to γ-tubulin (1:500 dilution; Sigma,
T6557). After washing three times in PBS, tissues were incubated with
appropriate Alexa Fluor dye–conjugated secondary antibodies (Goat Anti-Rabbit
488 (A11008), Goat Anti-Mouse 488 (A11001), Goat Anti-Rabbit 568 (A11011)
and Goat Anti-Mouse 568 (A11031), Invitrogen) at a dilution of 1:400 for 1 h.
Tissues were washed in PBS and incubated for 5 min in 2 µg/ml Hoechst 33342
(Sigma) for counterstaining of nuclei. Secondary antibodies alone were used as a
control. Whole mounts were placed onto depressed glass slides, and cover slips
with CoverWell imaging chambers (Grace Bio-Labs) were applied. Samples were
imaged either on a Carl Zeiss Axiovert 200M inverted microscope with an
ApoTome attachment and Axiovision 4.6 software (Carl Zeiss) or on a Leica TCS
SP2 confocal laser scanning microscope.
2.5.3 Transmission Electron Microscopy (TEM)
To collect brains, mice (12 d old) were perfused transcardially with 0.9% saline
followed by 2% paraformaldehyde/2.5% glutaraldehyde in 0.1 mM phosphate
buffer. Brain samples were further fixed by immersion overnight in 2%
paraformaldehyde/2.5% glutaraldehyde in 0.1 mM phosphate buffer and were
washed in phosphate buffer three times for 40 min per wash. Sections were
postfixed with 2% OsO4 in 0.1 mM phosphate buffer for 1.5 h and were
dehydrated through a graded ethanol series. After dehydration, tissues were
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washed twice in acetone and embedded in epoxy resin in capped inverted Beem
capsules. Thin sections were cut with a diamond knife, placed onto Formvarcoated slot grids and heavy metal stained with uranyl acetate and lead citrate.
Trachea tissues were directly dissected without perfusion and were fixed by
immersion overnight in 2% paraformaldehyde/2.5% glutaraldehyde in 0.12 mM
phosphate buffer. They were washed in phosphate buffer three times (60 min in
total), postfixed in 1% OsO4 and 0.8% potassium ferricyanide in 0.12 M
phosphate buffer for 1 h, dehydrated through a graded ethanol series, rinsed
twice in acetone and embedded in epoxy resin. Thin sections were cut with a
diamond knife, placed on copper grids and heavy metal stained with ethanolic
uranyl acetate and Sato's lead citrate. Electron micrographs were captured using
an FEI Tecnai 12 Biotwin TEM equipped with a side-mounted AMT XR-40 CCD
camera.

2.5.4 Scanning electron microscopy
Wild-type and mutant mouse embryos (E7.5) were collected and fixed in 1.5%
paraformaldehyde/1.5% glutaraldehyde in 0.10 M sodium cacodylate containing
0.05 M NaCl overnight at 4 °C. Samples were postfixed with 2% OsO4 in the
same buffer overnight and were dehydrated using a graded ethanol series.
Specimens were dried in a Polaron E3000 Critical-Point Dryer and mounted onto
aluminum specimen mounts (Ted Pella) using carbon tape and silver paint
(Ernest F. Fullam). Each mount was sputter coated with gold palladium (60%
gold, 40% palladium) using a Polaron E5100 Sputter Coater. Samples were
	
  

57

	
  
examined and photographed using a LEO DSM982 field emission scanning
electron microscope.
2.5.5 Protein blots of brain, lung and trachea lysates
Wild-type and mutant mouse brains and lungs were collected and lysed in RIPA
Buffer (Sigma) supplemented with 1× Protease Inhibitor Cocktail (Sigma). For
tracheal and lung preparation, tissues were dissected and carefully separated
from the surrounding tissues. Samples were homogenized using a tissue
homogenizer and cleared by centrifugation at 10,000g for 10 min. Proteins were
separated on 10% SDS-PAGE minigels and then transferred to Immobilon
(Millipore) membrane for protein blotting. For detecting DYX1C1 protein, the
antibody to N-terminal DYX1C1 (Sigma, SAB4200128) was used at a dilution of
1:200; antibody to GAPDH (Sigma, G8795) was used at a 1:1,500 dilution as a
loading control. LI-COR Odyssey infrared secondary antibodies (goat antibody to
mouse 680 (926-32220), goat antibody to mouse 800 (926-32210) goat antibody
to mouse 680 (926-32221) and goat antibody to mouse 800 (926-32211)) were
used at dilutions of 1:10,000. All blots were imaged and analyzed using a LI-COR
Odyssey Scanner and Software.
2.5.6 Videomicroscopy of ependymal flow and cilia in mice
P6–P10 wild-type and mutant mice were deeply anesthetized with isoflurane and
were then decapitated. Brains were rapidly removed and immersed in ice-cold
oxygenated (95% O2 and 5% CO2) dissection buffer containing 83 mM NaCl, 2.5
mM KCl, 1 mM NaH2PO4, 26.2 mM NaHCO3, 22 mM glucose, 72 mM sucrose,
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0.5 mM CaCl2 and 3.3 mM MgCl2. The lateral wall of the lateral ventricle was
dissected using a fine scalpel and forceps and was immediately observed in a
chamber containing buffer at 37 °C. For visualization of flow, a small amount of
India ink was placed on the surface of the lateral wall of the dissected ventricle.
Movement of India ink was observed and recorded using infrared DIC
microscopy (E600FN, Nikon) and a CCD camera (QICAM, QImaging, 120 frames
per second (fps)). For direct observation of cilia movement, mouse brains were
harvested as above, and coronal slices (400 µm) were cut using a vibratome
(Leica, VT1200S). Slices from the third ventricle through the fourth ventricle were
visualized using infrared DIC and a CCD camera. Images were analyzed with
ImageJ software (NIH).
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3. CELLULAR LOCALIZATION OF DYX1C1 AND
IDENTIFICATION OF ITS INTERACTION PARTNERS

3.1 Abstract
Dyx1c1 knockout mice display Primary Ciliary Dyskinesia (PCD) like phenotypes
that include Situs Inversus and early onset hydrocephaly. Live cell imaging and
an Indian ink flow assay indicated a lack of ciliary motility in the knockout mice
compared to the wildtype. Ultrastructural and immunofluorescence analyses of
Dyx1c1 mutant motile cilia in mice showed disruptions of outer and inner dynein
arms (ODAs and IDAs, respectively). Previous protein interaction studies suggest
possible roles for Dyx1c1 in chaperonin function (Chen et al 2009). In this study,
we determine the interaction partners of Dyx1c1 to understand its role in ciliary
motility. Immunoprecipitation and mass spectrometric analysis experiments
reveal that the Dyx1c1 interactome is enriched for proteins of the categories
molecular

chaperones

as

well

as

cytoskeletal

proteins.

We

find

by

immunoprecipitation experiments that Dyx1c1 interacts with heat shock proteins
and T-complex chaperones. Dyx1c1 also interacts with Septin2, a protein of the
ciliary transition zone with implicated function in ciliary protein trafficking.
Assessment of localization of Dyx1c1 identified that Dyx1c1 localizes to the
cytoplasm of nasal respiratory epithelial cells. We performed tracheal deciliation
to obtain axonemal and cilia-stripped tracheal fractions and further tested the
lysates for the presence of the ODA and IDA subunits. Interestingly, we found
that there was a reduction in the IDA subunit Dnali1 as well as ODA intermediate
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chains Dnai1, Dnai2 and light chains Dnal4 and Dnal1. Our observations thus
lead to the hypothesis that Dyx1c1 plays a role in cytoplasmic assembly of ciliary
dyneins and/or their transport to the ciliary transition zone.

3.2 Introduction

Dyx1c1, a 420 amino acid protein, was first identified as a candidate dyslexia
susceptibility gene112. The protein is ubiquitously expressed in brain, amongst
other tissues, and is found to localize to the in the nuclei and cytoplasm of
neurons and glia in human neocortex. The protein domains of DYX1C1 include
an N-terminal p23 and three C-terminal TPR domains. This combination of a p23
and TPR domains is shared with Sugtl, a protein known to play a role in
kinetochore assembly in yeast, suggesting a potential role in cell division or cell
dynamics. DYX1C1, when over-expressed in cell lines, can interact with Hsp70,
Hsp90 and an E-3 ubiquitin ligase, Chip, suggesting that DYX1C1 may also be
involved in the degradation of unfolded proteins127,128. At its C-terminal, there are
three tetratricopeptide domains (TPR) which function in protein-protein
interactions.

To elucidate the biological functions of Dyx1c1, exons 2-4 of Dyx1c1 were
deleted in mice. No detectable Dyx1c1 protein expression was observed by in all
tissues tested, including brain and lung. The knockout mouse exhibited PCD-like
phenotypes of situs inversus and hydrocephalus; both characterized by defects
of motile cilia. Light microscopy revealed the presence of cilia on the surface of
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the brain ependymal cells; however these cilia were completely immotile in the
KO as evidenced by the videomicroscopy analysis. Analysis into the
ultrastructural defects of the cilia exhibited an absence of both the inner and
outer dynein arms (IDA and ODA) that are responsible for the motility of the
cilia140.

Nonstructural cilia-associated proteins have been found to be mutated in PCD
individuals and result in the absence of outer and inner dynein arms. These
mutations involve proteins that are considered to function in cilia assembly or
“preassembly” pathways. Identification of the involvement of these proteins has
prompted research into the mechanisms of cilia biogenesis especially into the
following processes: intra-axonemal transport, transfer into the cilium, and
cytoplasmic preassembly56,141. The first PCD-associated preassembly protein
found was DNAAF2, the loss of which lead to complete absence of outer and
inner dynein arms. Localized within the apical region of the cell cytoplasm,
DNAAF2 interacts with Hsp90 and DNAI2 to facilitate assembly or dynein
complex transport into the cilia138. Mutations in the proteins DNAAF1 and
DNAAF3 caused outer dynein arm defects in patients with PCD102,104. Evidence
for assembly roles of these proteins is substantiated in mutant cells where
components of the dynein arm complex were found to either accumulate or
deplete from the mutant cytoplasm leading to a failure in their transport into the
ciliary axoneme. Mutations in LRRC6, a protein that is found in the cytoplasm but
colocalizes to the basal bodies, also lead to PCD142.
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Identification of the localization of Dyx1c1 will help us understand which of the
cilia biogenesis processes such as intra-axonemal transport, transfer into the
cilium, or cytoplasmic preassembly it is involved in. Also the previously defined
assembly factors function by interacting with the chaperones and the axonemal
dynein subunits of the dynein arms themselves. It is hence required to identify
the interaction partners of Dyx1c1 to detail its role in the ciliary motility. In this
study, we perform immunofluorescence analysis to find that Dyx1c1 localizes to
the apical cytoplasm of the ciliated cells. Furthermore, mass spectrometric
analysis identified the interactome of Dyx1c1, wherein the chaperone category of
proteins was enriched followed by the cytoskeletal proteins. We confirmed the
interaction of Dyx1c1 with the mass spectrometry (MS)-identified proteins like the
heat shock proteins Hsp70 and Hsp90; CCTs and Septin 2. We found that the
TPR domains of Dyx1c1 are necessary for mediating the interaction between
Hsp70 and CCTs; whereas the Hsp90 interaction was mediated via the p23
domain. We thus hypothesize that Dyx1c1 acts as a co-chaperone assisting in
the cytoplasmic preassembly of the axonemal dyneins and their subsequent
transport to the base of the cilium at the transition zone.

3.3 Results
3.3.1 Sub-cellular localization of Dyx1c1
To characterize the functional role of Dyx1c1 in ciliary motility, it is necessary to
analyze the expression of Dyx1c1 in the ciliated tissues. Also, the phenotypes
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described above as well as previously reported interactions between
exogenously expressed DYX1C1 protein and molecular chaperones suggested
to us that DYX1C1 might function as a newly identified axonemal dynein
assembly factor. We found by immunofluorescence that mouse Dyx1c1 protein
was located in the cytoplasm of respiratory epithelia (Fig. 3-1).

Figure 3-1: Dyx1c1 localizes to the cytoplasm of ciliated epithelial cells.
Immunofluorescence analyses of mouse nasal epithelial cells stained for
acetylated tubulin (green) and Dyx1c1 (red). In Dyx1c1+/+ mice, Dyx1c1 localizes
to the cytoplasm of the epithelial cells and partly to the basal bodies but is absent
in the cilia. In the mutant, Dyx1c1 is absent from the cytoplasma. Nuclei were
stained with Hoechst 33342 (blue).

In order to confirm the cytoplasmic localization of Dyx1c1; we developed a
protocol for separation of the ciliary axonemes from the trachea of Dyx1c1
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wildtype and knockout mouse. After harvesting tracheas in cold PBS, they were
then incubated in chilled buffer containing 20mM calcium that induces deciliation
of the trachea. The mechanism underlying Ca++ induced deciliation involves a
calcium-binding protein centrin, which is a part of the stellate fibers of the
transition zone, contraction of which causes the severing of microtubules at the
transition zone. The region of the detached cilia seals over, minimizing the
protein leakage out of the cell body87. The tracheas were then separated from the
buffer containing the ciliary axonemes, and incubated in lysis buffer to obtain the
cytoplasmic fraction that contains the trachea stripped of the axonemes. The
axonemal fraction was further spun down at low speed to pellet any cellular
debris. The pellet is discarded and the axoneme-containing buffer is further spun
down at high speed for about 30 min to pellet the axonemes, which are then
incubated in lysis buffer to get the axonemal lysate.
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Figure 3-2: Deciliation of Dyx1c1 wildtype and knockout trachea (a) Deciliation
workflow. (b) Immunofluorescence analysis of the axonemal fraction of the wildtype
(left panel) and knockout (right panel) using anti-acetylated tubulin (cilia, red) and
Hoechst (nuclear stain, blue). (c) Coomassie stained gel showing the axonemal and
deciliated tracheal lysates of the wildtype and knockout. (d) Western blot probed with
acetylated tubulin, Gapdh (control) and Dyx1c1. Axo: axonemal fraction; Cyto:
cytoplasmic fraction.
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We thus obtain two fractions after the deciliation workflow (Fig. 3-2a): i)
cytoplasmic fraction containing the trachea stripped off the ciliary axoneme and
ii) axonemal fraction consisting of the ciliary axoneme. The separated axonemes
were analyzed for their purity by using immunofluorescence analysis (Fig. 3-2b).
It was observed that there was little to no contamination of the cells in the
axonemal preparation. The deciliation was confirmed by Coomassie staining (Fig.
3-2c) and western blot (Fig. 3-2d). Western blot was performed using lysates of
the whole trachea, cytoplasmic extract, and axonemal extract of both the Dyx1c1
wildtype and knockout, and the blot was stained with acetylated tubulin (a marker
for cilia), Gapdh, as well as Dyx1c1 (Fig. 3-2d). We found that the wildtype and
knockout axonemal fraction expressed acetylated tubulin with little contamination
of the Gapdh-containing cytoplasmic fraction and vice-versa; whereas the whole
trachea from the Dyx1c1 wildtype and knockout mice showed the presence of
both Gapdh and acetylated tubulin. We also showed that Dyx1c1 is present in
the cytoplasmic fraction of the wildtype trachea and absent from the wildtype
axonemal and knockout cytoplasmic as well as axonemal fraction. Gapdh was
used as the marker for the cytoplasmic fraction (Fig. 3-2d).
3.3.2 Identification of the interaction partners of Dyx1c1
To categorize the molecular function of Dyx1c1 more completely in respiratory
tissue, we defined the protein interactome of Dyx1c1 in mouse trachea by coimmunoprecipitation and tandem mass spectrometry. We prepared input extracts
for co-immunoprecipitation from the tracheal tissue of either wildtype or mutant
mice and found that these appeared similar in protein composition, as evaluated
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by Coomassie staining after SDS-PAGE. After co-immunoprecipitation with
antibodies to Dyx1c1, Coomassie-stained protein bands were apparent in
preparations from wild-type extracts but not in those generated from mutant
extracts. We cut 14 matched pairs of gel pieces covering the range from
approximately 20 to 200 kDa, with many pieces containing multiple bands, from
wild-type and mutant co-immunoprecipitations and subjected them to tryptic
digestion and tandem mass spectrometry analysis for protein identification. In all,
we identified 702 proteins in immunoprecipitates from wild-type trachea and 29
proteins in gel slices from the immunoprecipitates from trachea expressing
mutant protein (Supplementary Table 1).
To determine whether the identified Dyx1c1 protein interactome was enriched for
particular molecular or biological functions, we used the Database for Annotation,
Visualization and Integrated Discovery (DAVID) to determine the presence of
enriched Panther Gene Ontology terms in the Dyx1c1 interactome and proteins
identified in the knockout control. Using a mouse lung proteome as background,
we found several molecular functional categories enriched in the Dyx1c1
interactome, and several of these were in categories containing molecular
chaperones (MF00077: chaperone, P < 0.001; MF00091: cytoskeletal proteins, P
< 0.001; BP00062: protein folding, P < 0.01; BP00072: protein complex assembly,
P < 0.05; and MF00078: chaperonin, P = 0.05; Table 3-1). All four of these
chaperone-containing categories were not significantly enriched in the protein set
identified in the immunoprecipitates with mutant protein (Table 3-1).
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Table 3-1: Complete list of PANTHER Gene Ontology enrichment terms from Dyx1c1
wild-type subtracted by knockout control with a lung proteome as a background.
Thick horizontal line separates statistically significant terms (p < 0.05) from nonstatistically significant terms (p > 0.05).

	
  

The DYX1C1 interactome contained a total of 28 proteins in the chaperone or
chaperonin category, including 6 of 8 subunits in the T-complex chaperonin
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complex and multiple heat-shock proteins. In addition to the chaperones, another
interesting family of proteins, Septins, was identified as a part of the Dyx1c1
interactome.
Septins are evolutionarily conserved family of small GTPases that form heterooligomers, which assemble into filaments, rings and spirals.

In mammals,

Septins have been linked to scaffolding functions with the cytoskeleton especially
through their interactions with actins. Sept2 interacts with MAP4 that positively
regulates the polymerization/stability of cytoplasmic microtubules. Map4 directly
binds and bundles microtubules in turn regulates the Septin-microtubule
interactions. Septins organize lateral membrane diffusion barriers between the
ciliary compartment and the surrounding plasma membrane in the sperm
flagellum143, primary cilium3 and motile cilia. The transition zone includes the
region where the basal body is docked onto the cellular membrane, and extends
distally to link microtubule doublets to the ciliary membrane by Y-shaped
molecular links. Septins form a ring-shaped structure at the base of cilia. Sept2 is
also required for ciliogenesis, thereby linking septins to ciliary function and
morphogenesis3,143. The mass spectrometric analysis performed on the wildtype
immunoprecipitates identified Septin2 and Septin 7 as a part of the Dyx1c1
interactome.
Cytoplasmic dyneins are thought to be involved in linking dynein to cargos and to
adapter proteins thus regulating dynein function. Cytoplasmic dynein also acts as
a motor for the intracellular retrograde motility of vesicles and organelles along
microtubules. The intermediate chains of the cytoplasmic dyneins are known to
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mediate the binding of dynein to dynactin via the 150 kDa component of DCNT1;
thus functioning in membrane-transport. Our MS/MS screen identified the
intermediate chain of the cytoplasmic dyneins, Dync1i1.
We confirmed the interaction of Dyx1c1 with Hsp70, Hsp90, Cct3, Cct4, Cct5,
Cct8, Sept2 and Dync1i1 by co-immunoprecipitation and western blot analysis
(Fig. 3-3).

Figure 3-3: Identification of interaction partners of Dyx1c1. Coimmunoprecipitations and western blot analyses show the interaction of Dyx1c1 with
the chaperones Cct3, Cct4, Cct5, Cct8, Hsp70 and Hsp90. Dyx1c1 also interacts with
cytoplasmic dynein 1 intermediate chain 1 (Dync1i1) protein as well as Septin-2
(Sept2).

3.3.3 Interaction of Dyx1c1 with the interaction partners in HEK cells
Dyx1c1 protein contains N-terminal heat shock protein family domain and Cterminal TPR domains that are known to mediate protein-protein interactions.
TPR-containing proteins have been previously studied for their roles in molecular
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protein complexes, anaphase promoting complexes, transcription repression
complexes, and the organization of protein import complexes128.
3.3.3.1 Interaction of Dyx1c1 with heat shock proteins Hsp70 and Hsp90
Dyx1c1 is known as a co-chaperone due to its previously identified interactions
with the heat shock proteins Hsp70 and Hsp90. It is known that Dyx1c1 interacts
with Hsp70 via its TPR domains while the p23 is sufficient for the interaction of
Hsp90 and Dyx1c1. Our MS/MS data identified chaperones Hsp70 and Hsp90 in
the interactome of Dyx1c1; we confirmed that Dyx1c1 interacts with both Hsp70
and Hsp90 (Fig 3-3). We decided to investigate this interaction in a heterologous
expression system. We transfected HEK cells with the full-length, N-terminal
truncation and C-terminal truncation constructs of Dyx1c1 all fused to GFP; and
decided to investigate the interaction of full-length and truncation constructs of
Dyx1c1 with endogenous Hsp70 or Hsp90 (Fig. 3-4). We found that Dyx1c1 fulllength protein co-immunoprecipitated with both Hsp70 and Hsp90. The TPR
domains mediated the interaction of Hsp70 while the p23 domain aided that of
Hsp90.
3.3.3.2 Interaction of Dyx1c1 with the T-complex chaperones
Chaperonins are large double-ring complexes of ~800−900 kDa that function by
enclosing substrate proteins up to ~60 kDa for folding. Group I chaperonins (also
known as HSP60s in eukaryotes and GroEL in bacteria) have seven-membered
rings in bacteria, mitochondria and chloroplasts, and functionally cooperate with
HSP10 proteins (GroES in bacteria), which form the lid of the folding cage. The
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most complex group II chaperonin is however the eukaryotic cytosolic chaperonin
containing TCP1 [CCT, also termed TRiC (TCP1 ring complex)], which is
composed of eight different subunits (CCTα, β, γ, δ, ɛ, ζ, η and θ in mammals,
CCT1–8 in yeast) organized in a unique intra- and inter-ring arrangement. They
are independent of HSP10 factors144-147. They are known to be involved in the
quality control of cytoskeletal proteins and also tubulin biogenesis.
Our MS/MS screen identified four of the eight CCTs Cct3, Cct4, Cct5 and Cct8.
We confirmed by co-immunoprecipitation and protein blot analysis the
interactions of these four six chaperones with DYX1C1 (Fig. 3-3). We also further
confirmed the interaction of Dyx1c1 with these Ccts heterologously. We used
HEK cell lysates transfected with full-length Dyx1c1, N-terminal and C-terminal
truncation constructs of Dyx1c1 to pull down Dyx1c1 protein; and further blotted
with the Cct antibodies to test for the interaction of Dyx1c1 with the Ccts. We
found that all the Ccts interacted with Dyx1c1 via the TPR domains (Fig. 3-4).
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Figure 3-4: Dyx1c1 interacts with the chaperones. (a) Co-immunoprecipitation and
western blot analysis shows that transfected Dyx1c1-GFP interacts with endogenous
HSp70 and Hsp90; Dyx1c1-∆p23-GFP interacts with Hsp70; while Dyx1c1-∆TPRGFP interacts with Hsp90. (b) Co-immunoprecipitation and western blot analysis
shows that transfected Dyx1c1-GFP interacts with endogenous Cct3, Cct5 and Cct8.
Dyx1c1-∆p23-GFP interacts with the CCTs. GFP condition acts as a control.
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3.3.4 Cytoplasmic abundance of dynein subunits of IDA and ODA
Previous studies have shown that Chlamydomonas can disassemble and
subsequently reassemble their flagella once each cell cycle while maintaining a
cytoplasmic pool of flagellar dynein subunits enough to assemble half-length of
the flagella in the absence of any protein synthesis148,149. The dynein assembly
mutations could either prevent the dynein complex from preassembling in the
cytoplasm or block the IFT-mediated transport of the assembled complex into the
flagella. In order to understand the Dyx1c1 aided assembly process it is hence
important to examine the cytoplasmic pool of axonemal proteins by biochemical
analysis. Loss of function of the previously studied assembly factors Ktu and
Lrrc50 reduces the abundance of some ODA HC subunits while increasing the
abundance of the ODA IC subunits in the cytoplasm. In the Lrrc6 mutant
cytoplasm, the ODA HCs are retained at wildtype levels while the IC subunit
Dnai2 is hyperabundant, which suggests that the Lrrc6 mutation has an effect on
the assembly of heavy chains with intermediate chains56,102,150.
In order to assess the cytoplasmic abundance of the dynein subunits in the
cytoplasm of the Dyx1c1 mutant, we performed deciliation of the trachea
obtained from wildtype and knockout Dyx1c1 mice. We confirmed the
cytoplasmic localization of Dyx1c1 in the wildtype extracts and the deciliation was
confirmed by the presence of acetylated tubulin only in the axonemal fraction
with little to no expression in the cytoplasmic extract using Gapdh as the control
for the cytoplasmic fraction. Having confirmed the deciliation, we then decided to
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investigate the abundance of the dynein subunits in the cytoplasmic fraction
obtained from the WT and KO trachea.

Figure 3-5: Outer dynein arm intermediate and light chain subunits are reduced
in the Dyx1c1 knockout tracheal cytoplasm. Western blot analysis (top panel) and
quantification (bottom) of the dynein subunits shows reduced cytoplasmic abundance
of Dnai1 (red) (a), Dnai2 (red) (b), Dnal1 (red) (c), and Dnal4 (red) (d). Gapdh is used
as a loading control and for normalization. Student’s T-test, P-value<0.01(*); P-value
<0.05 (**).

Western blots of cytoplasmic extracts showed that in the Dyx1c1 knockout
cytoplasm, the abundance of ODA intermediate chains Dnai1 (Fig. 3-5a) and
Dnai2 (Fig. 3-5b) was reduced. Compared to the wildtype cytoplasm, the levels
of Dnai1 were decreased by about half whereas the levels of Dnai2 were
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reduced by 99% in the knockout cytoplasm. In addition to the intermediate chains,
the abundance of some of the light chains was altered as well in the knockout
cytoplasm. There was a seven-fold decrease in the abundance of the light chain
Dnal1 (Fig. 3-5c), while a 98% reduction in abundance of Dnal4 (Fig. 3-5d) in the
knockout cytoplasm when compared to the wildtype cytoplasm. Thus, the Dyx1c1
mutation suggests a defect in assembling the intermediate chains and/or light
chains of the ODA complex or the maintenance of these axonemal dyneins.
Since ultrastructural studies of the cilia from the Dyx1c1 knockout mice show the
absence of both the inner and outer dynein arms as well as the
immunocytochemistry indicates the lack of expression of the IDA subunit Dnali1
from the mutant ciliary axoneme, we looked at the abundance of the IDA light
intermediate chain subunit Dnali1 (Fig. 3-6). We found that the cytoplasmic
abundance of the light intermediate chain Dnali1 was also reduced to about 4%
in the knockout cytoplasm compared to the wildtype.

Figure 3-6: Inner dynein arm light intermediate chain Dnali1 is reduced in the
Dyx1c1 knockout tracheal cytoplasm. Western blot analysis (left panel) and
quantification (right panel) of Dnali1 shows reduced cytoplasmic abundance. Gapdh
is used as a loading control and for normalization. Student’s T-test, P-value<0.01(*).

	
  

77

	
  
The results suggest that, in the cytoplasm of the Dyx1c1 knockout tracheal cells,
the ODA intermediate chain subunits Dnai1 and Dnai2; the ODA light chain
subunits Dnal1 and Dnal4; as well as the IDA light intermediate chain subunit
Dnali1 might be undergoing rapid degradation due to the lack of their
incorporation into the ODA or IDA complex. Thus we propose that Dyx1c1 is
indeed required for the cytoplasmic preassembly of the ciliary dyneins and the
absence of which leads to protein degradation due to the defect in the assembly
process.

3.4 Discussion

To identify the function of Dyx1c1 in ciliary motility, it was important to first
characterize the subcellular localization of the protein. Since the loss of Dyx1c1
is known to cause an absence of ODA and IDA in the ciliary axoneme, it could
localize to the ciliary axoneme and play in role in attachment of the ODA and IDA
to the microtubules; or Dyx1c1 could be a cytoplasmic protein functioning in the
assembly of the ODA and/or IDA or subsequent transport of the assembled
motor complexes to the base of the cilia.
When immunofluorescence analysis was performed on the acutely dissociated
nasal respiratory cells, we identified a cytoplasmic localization for Dyx1c1. Three
other proteins, termed as assembly factors of axonemal dyneins, DNAAF1,
DNAAF2 and DNAAF3 are identified that localize to the cytoplasm and are
involved in the pre-assembly of the axonemal dyneins before their transport into
the ciliary axoneme. Due to the cytoplasmic localization of Dyx1c1, we proposed
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that Dyx1c1 probably functions like the assembly factors mentioned above.
Dyx1c1 has identified as a co-chaperone due to its interaction with the heat
shock proteins Hsp70 and Hsp90. In addition, Dyx1c1 is also implicated in
protein quality control due to its interaction with the E3 ubiquitin ligase, CHIP. To
characterize the function of Dyx1c1 in greater detail, we next identified the
interactome of Dyx1c1 by immunoprecipitation and mass spectrometric analysis.
We identified previously known interactors like the heat shock proteins Hsp70
and Hsp90; in addition to these, we also found a group of chaperonins (Tcomplex chaperones) that interact with Dyx1c1. We further identified that the
TPR domains of Dyx1c1 are critical for the interaction of the Hsp70 and CCTs
with Dyx1c1, while the p23 domain of Dyx1c1 mediates the interaction with
Hsp90. These results validate the function of Dyx1c1 in chaperone-mediated
processes or especially as a co-chaperone. In addition, Dyx1c1 interactome also
consisted of proteins that are a part of the proteasomal degradation pathway.
Due to these findings, we speculate that Dyx1c1 might be involved in the quality
control or stability of the unfolded protein complexes. It might however also be
involved in the degradation of the misfolded protein complexes due to its
association with the proteasomal pathway subunits as well as its previously
known interaction with CHIP.
Interestingly, the newly identified interaction partner of Dyx1c1, Sept2, hints at a
role of Dyx1c1 at the transition zone of the cilium. We have hypothesized that
Dyx1c1 is involved in the cytoplasmic preassembly of ciliary dyneins. Once these
ciliary dyneins have assembled in the cytoplasm, they need to be transported to
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the transition zone before entering the axoneme. Dyx1c1 might be responsible
for the stability of the assembled dynein arm complexes and hence might be
transporting this complex to the Sept2-containing transition zone, where the
motor complex then gets docked onto the intraflagellar transport (IFT) complex.
The cytoplasm of the ciliated epithelial cells generates a precursor ODA and IDA
motor complex, hence investigation into the cytoplasmic abundance of the ODA
and IDA dynein subunits will give us insights into the biochemical function of
Dyx1c1. We performed deciliation of the trachea obtained from the WT and KO
to assess the abundance of the ODA and IDA subunits in the deciliated tracheal
lysates. Interestingly, we found that the ODA intermediate chain subunits Dnai1
and Dnai2 were depleted from the KO cytoplasm; as were the ODA light chain
subunits Dnal1 and Dnal4. The light intermediate chain subunit of the IDA
complex, Dnali1, was also reduced in the KO cytoplasm compared to the control.
These results suggest that Dyx1c1 is probably required for the proper folding of
these subunits in the KO; in the absence of Dyx1c1, the subunits fold abnormally
leading to their rapid degradation. Alternatively, the axonemal dynein subunits
might be folded correctly, but due to the lack of Dyx1c1 their incorporation as an
ODA or IDA is affected. Since the subunits are not assembled accurately, they
might be degenerating at a faster rate in the KO than the WT. A third possibility is
that Dyx1c1 plays a role in the transcriptional regulation of the axonemal dynein
subunits and loss of Dyx1c1 affects the synthesis of the proteins.
In summary, we hypothesize that Dyx1c1 plays a role in the cytoplasmic
preassembly of the axonemal dyneins mediated by its interaction with the
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chaperones. It might also assist in the stability of the individual dynein subunits or
the assembled ODA/IDA complex. Due to the interaction of Dyx1c1 with Sept2,
we also predict that Dyx1c1 is required for the transport of the assembled ODA
or IDA complex to the transition zone, which is the checkpoint for the assembled
motor complex to enter the axoneme.

3.5 Materials and Methods
3.5.1 Immunofluorescence of dissociated mouse nasal epithelial cells
Nasal epithelial cells were harvested from mouse septa by acute dissociation on
a 4-well slide in 1:1 PBS/HBSS. Slides were dried to let the cells adhere to the
wells, and cells were immediately fixed with 4% paraformaldehyde for 2 min at
room temperature. Cells were then washed twice with 1× PBS for 2 min for each
wash. Blocking buffer (10% goat serum and 0.1% Triton X-100 in 1× PBS) was
added for 15 min at room temperature. Slides were incubated with rabbit
polyclonal antibody to DYX1C1 (Sigma, SAB4200128) at a 1:500 dilution and
mouse monoclonal antibody to acetylated tubulin (Sigma, T7451) at a 1:1,000
dilution in the same blocking buffer for 30 min at room temperature. After three
washes with 1× PBS for 5 min each, slides were incubated with Alexa Fluor 488–
conjugated goat antibody to rabbit (Invitrogen, A11034; 1:5,000 dilution) and
Alexa Fluor 568–conjugated goat antibody to mouse (Invitrogen, A11031;
1:1,000 dilution) for 20 min at room temperature. Slides were washed twice with
1× PBS for 5 min each, and nuclear stain Hoechst 33342 (Invitrogen, H3570) at a
1:2,500 dilution was added for 15 min at room temperature. Slides were dried,
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and cover slips were applied with Prolong Gold Antifade (Invitrogen, P36930).
Cells were imaged on a Leica TCS Sp2 laser scanning microscope.
3.5.2 Basic peptide identification by tandem mass spectrometry
After separation by SDS-PAGE, proteins were stained with Coomassie dye.
Fourteen gel pieces were excised from the gels that contained bands in the
immunoprecipitates with wild-type Dyx1c1 or were adjacent to these bands in the
lane containing immunoprecipitates with mutant Dyx1c1. Bands were in-gel
digested with trypsin, and resulting peptides were analyzed using liquid
chromatography tandem mass spectrometry on a Thermo Scientific LTQ-Orbitrap
XL mass spectrometer equipped with Waters nanaoACQUITY ultra-highpressure liquid chromatographs (UPLCs) for peptide separation. The liquid
chromatography tandem mass spectrometry data were searched with an inhouse Mascot algorithm for uninterpreted tandem mass spectrometry spectra
after using the Mascot Distiller program to generate Mascot compatible files.
Charge states of +2 and +3 were preferentially located with a signal-to-noise ratio
of 1.2 or greater, and a peak list was generated for database searching. NCBInr,
a mouse- specific database (in FASTA format), was used for searching.
3.5.3 Tandem mass spectrometry and gene ontology enrichment analysis
Raw tandem mass spectrometry peptide sequencing results for the wild-type and
control analyses obtained from the Yale W.M. Keck Foundation Proteomics
Resource were stringently filtered to ensure a low false positive protein
identification rate. Specifically, proteins were considered identified only if they
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contained two or more unique peptides with expectation values of <0.01.
Resulting unique protein GI accession numbers for the wild-type and controls
were separately used as inputs for the DAVID bioin- formatics resource with the
mouse proteome selected as the background49,50. To detect enrichment in
gene ontology terms associated with the input pro- teins, the PANTHER
biological process and PANTHER molecular function annotations were selected,
and functional annotation charts were generated. To further account for highabundance proteins commonly observed in tandem mass spectrometry analyses,
a list of 1,000 mouse protein Swiss-Prot accession numbers was obtained from
the Global Proteome Machine web site and was used as an alternate
background in the DAVID gene ontology analysis of DYX1C1 interactors.
3.5.4 Deciliation of the trachea
The tracheas harvested from postnatal day 16 (P16) Dyx1c1 wildtype and
knockout mice were washed with cold phosphate-buffered saline to remove
mucus and cell debris. Animal procedures were performed under protocols
approved by the Institutional Animal Care and Use Committee of the University of
Connecticut and conform to US NIH guidelines. The dissected tracheas were
transferred to a separate tube containing deciliation buffer containing 10mM TrisHCl (pH 7.5), 50mM NaCl, 20mM CaCl2, 1mM EDTA, 0.1% TritonX-100, 7mM
betamercaptoethanol, and 1% volume of protease inhibitor mixture; incubated for
10 min with intermittent mild vortexing. The supernatant was collected in a
separate tube, and the procedure was repeated twice. The tracheas were then
separated from the supernatant, the three washings were pooled, and after
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pelleting cell debris at 800xg, the ciliary axonemes were collected by
centrifugation at 20,000xg. Ciliary axonemal pellets were resuspended gently in
30 mM Hepes (pH 7.3), 1 mM EGTA, 0.1 mM EDTA, 25 mM NaCl, 5 mM MgSO4,
1 mM dithiothreitol, and 1% volume of protease inhibitor mixture (Sigma). Triton
X-100 was added (0.5%) to the suspension, and the axonemes were incubated
for 15 min on ice, followed by centrifugation. The lysates containing the
axonemal fraction were then frozen at -80°C. The cilia-stripped-tracheas were
incubated in RIPA buffer (Sigma) on ice for 20 min. Samples were homogenized
using a tissue homogenizer and cleared by centrifugation at 10,000g for 10 min
to obtain the protein lysate of the cytoplasmic fraction of the trachea. Protein
concentrations were estimated using the BCA reagent (Pierce).
3.5.5 Protein blots of whole trachea, cytoplasmic and axonemal lysates
For whole tracheal preparation, tracheal tissues were dissected from wildtype
and knockout mice, and carefully separated from the surrounding tissues. After
incubation in RIPA Buffer supplemented with 1× Protease Inhibitor Cocktail
(Sigma), samples were homogenized using a tissue homogenizer and cleared by
centrifugation at 10,000g for 10 min. The cytoplasmic and axonemal fractions of
the trachea were prepared as described above. Proteins were separated on 12%
SDS- PAGE minigels and then transferred to Immobilon (Millipore) membrane for
protein blotting. For detecting DYX1C1 protein, the antibody to N-terminal
DYX1C1 (Sigma, SAB4200128) was used at a dilution of 1:200; antibody to
acetylated tubulin (Sigma, T6793) was used at a dilution of 1:2000; and antibody
to GAPDH (Sigma, G8795) was used at a 1:1,500 dilution as a loading control.
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LI-COR Odyssey infrared secondary antibodies (goat antibody to mouse 680
(926-32220), goat antibody to mouse 800 (926-32210), goat antibody to rabbit
680 (926-32221) and goat antibody to rabbit 800 (926-32211)) were used at
dilutions of 1:15,000. All blots were imaged and analyzed using a LI-COR
Odyssey Scanner and Software.
3.5.6 Cell culture and transfection
Human embryonic kidney (HEK293T) cells were grown to confluence in DMEM
supplemented with 10% FBS, 1% non-essential amino acid (NEAA) and 1%
penicillin-streptomycin antibiotics (Invitrogen). Cultures were plated at a density
of 106 cells on a 10-cm petridish. DNA (24 µg) was added to the petridish with 75
µl of Lipofectamine 2000 reagent (Invitrogen) in OptiMEM-1. The transfection mix
was added to cells in normal growth media and incubated for 48 h at 37 °C. To
obtain the protein lysates from the cells, the normal growth media was removed
and the cells were washed with PBS. The cells were then collected, centrifuged
to pellet the cells and the pellet was incubated in RIPA buffer supplemented with
1X Proteinase Inhibitor Cocktail for 20 min on ice. The lysates were then
centrifuged at 2000xg to pellet the debris. Protein blots were also performed on
the transfected cells as described above.

	
  

85

	
  

4. CHARACTERIZATION OF MUTANT DYX1C1 PROTEIN
AND ITS INTERACTIONS
4.1 Abstract
Defects in motile cilia cause primary ciliary dyskinesia (PCD), characterized by
chronic airway disease, infertility, and left-right laterality disturbances. Dyx1c1
(DNAAF4) was identified as a candidate PCD gene, mutations in which resulted
in loss of the outer and inner dynein arms. 12 biallelic PCD-causing mutations
were identified in Dyx1c1, which were speculated to cause either protein
degradation or a truncated protein product lacking the TPR domains of Dyx1c1.
Interestingly, a novel missense mutation p.Leu19Glu was identified in a Druze
cohort that coincidentally segregated with PCD. The patients suffer from the
classical PCD symptoms and the patient cilia show an absence of inner dynein
arms. Here, we show that the DYX1C1 protein is produced in the patients at the
correct molecular weight. The ODA intermediate chain, DNAI2 and IDA light
intermediate chain, DNALI1 are reduced in the patients. The interactor proteins
of Dyx1c1, Sept2 and Ktu, were not reduced in abundance in the patients.
Interaction of Dyx1c1 between Sept2 and Ktu was studied heterologously to
demonstrate a reduction in their association with Dyx1c1 mutant protein. Thus,
DYX1C1 is an essential ciliary protein required for the cytoplasmic preassembly
of both the ODAs and IDAs.

4.2 Introduction
Primary ciliary dyskinesia (PCD [MIM 244400]) is a genetically heterogeneous
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autosomal-recessive disorder affecting 1 in 15,000–30,000 births and is caused
by abnormal function of motile cilia and flagella. Abnormal motility is associated
with axonemal ultrastructural defects, giving rise to symptoms including
pulmonary disease, which is due to impaired mucociliary transport in the airways.
Mutations that cause PCD have been reported in 19 genes, all of which are
associated with various ultrastructural defects, mutations in which might
contribute to syndromic PCD. These 19 genes include those encoding axonemal
proteins of the ODA or its docking complex (DNAH5, DNAH11, DNAI1, DNAI2,
DNAL1, TXNDC3, and CCDC114), the radial spoke heads (RSPH4A and
RSPH9), the central-pair apparatus (HYDIN), or the nexin-dynein regulatory
complexes (CCDC164, CCDC39, and CCDC40). A distinct set of six proteins
altered in PCD are either solely localized to the cytoplasm or found in both the
cytoplasm and the axoneme: DNAAF1 (LRRC50), DNAAF2 (KTU), DNAAF3,
CCDC103, HEATR2, and LRRC6. These are most likely involved in the
cytoplasmic preassembly of dynein-arm complexes prior to their movement into
the axoneme and/or in axonemal transport and attachment processes for the
dynein-arm complexes.
Our results described in Chapter 2 and 3 suggest that Dyx1c1 can also be
considered as an axonemal dynein assembly factor due to its cytoplasmic
localization and its involvement in ciliary motility. Studies performed using the
morpholino-mediated

knockdown

approach

in

zebrafish,

confirmed

an

evolutionarily conserved role of Dyx1c1 in the ciliary function. Morpholinomediated knockdown of zebrafish dyx1c1 resulted in hydrocephalus, kidney cysts
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and body-axis curvature, phenotypes consistent with ciliary dysfunction in
zebrafish. Morpholino-mediated knockdown of dyx1c1 also produced laterality
defects in dyx1c1-morphant embryos at 48 h post-fertilization140.
Owing to the conservation of function of Dyx1c1 in mice and zebrafish, studies
were initiated to search for mutations in DYX1C1 in humans with PCD. DYX1C1,
located on chromosome 15q21.3, comprises ten exons (translation starts in exon
2) and encompasses 77.93 kb of genomic DNA. A total of nine human DYX1C1
mutations were identified as shown in Fig. 4-1a. Apart from a 3.5-kb deletion and
a splice-site mutation, the other seven mutations were predicted to cause
premature protein termination and clustered toward the middle of the 420-aminoacid sequence, between amino acids 128 and 195 (Fig. 4-1b). Thus, seven of
the nine identified mutations are predicted to result in a truncated DYX1C1
protein that would lack more than half of the protein, including the C-terminal
tetratricopeptide-repeat (TPR) domain. The TPR domains in DYX1C1 have been
shown previously to be functionally important domains required for the activities
of DYX1C1 in neuronal motility, its cellular localization and its interaction with
molecular chaperones. All the 12 individuals with biallelic DYX1C1 mutations
suffered from classical symptoms of PCD, including recurrent upper and lower
airway disease and bronchiectasis. Thus, DYX1C1 deficiency in humans causes
disruption of left-right body asymmetry, similar to the findings observed in mice
and zebrafish.
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Figure 4-1: DYX1C1 mutations in PCD patients. (a) Schematic presentation of
chromosome 15 and the genomic structure of DYX1C1. The positions of 8 identified
mutations are indicated by black arrows, the position of the 3.5kb deletion is indicated
by a rectangle. (b) Schematic showing the relative positions of seven DYX1C1
nonsense mutations identified in PCD patients and families in the DYX1C1 coding
sequence. All mutations are clustered in the middle of DYX1C1 coding sequence and
each mutation predicts to cause a premature stop prior to the tetricopeptide repeat
domains (TPR) at the C-terminus of DYX1C1 (CS: p23-like C-terminal CHORD-SGT1
domain). (Adapted from Tarkar et al. 2013)

In addition to the above already published data regarding the mutations identified
in DYX1C1 causing PCD in humans, our collaborators identified a novel mutation
in DYX1C1 p.L19Q (unpublished). This mutation was recently identified in an inbred family belonging to the Druze community of the Golan Heights in Israel. The
patients with this mutation suffer from the classical PCD symptoms of recurrent
upper and lower respiratory tract infections. This point mutation p.L19Q leads to
the substitution of Glutamine for Leucine in the p23 domain of DYX1C1, which is
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a domain belonging to the heat shock protein family. This mutation leading to
non-polar to polar switch of amino acid, might disrupt the intermolecular contacts
leading to altered native structure of the Dyx1c1 protein. It might also potentially
have an effect on the interactions of Dyx1c1 protein mediated by the p23 domain.
It is hence critical to evaluate the protein expression of Dyx1c1 in the patients as
well as assess the interactions of Dyx1c1 with its known interactors, to gain
insights into the function of Dyx1c1.

4.3 Results:
4.3.1 Expression profile of Dyx1c1 protein in the Druze mutant
Mutations in DYX1C1 have been identified that are known to cause PCD in
humans; however all the previously known human mutations are postulated to
generate either a truncated protein product lacking the C-terminal TPR domains
or led to non-sense mediated decay. The novel DYX1C1 mutation p.L19Q is
identified in the p23 domain of Dyx1c1, and hence it is interesting to evaluate
whether this mutation leads to degradation or a truncated Dyx1c1 protein product.
In order to characterize the mutation heterologously, we obtained a plasmid
construct of Dyx1c1 harboring this mutation (Dyx-Mut). To assess for the protein
expression, we transfected this construct in HEK cells and performed western
blot analysis. We thus confirmed that Dyx-Mut construct produced Dyx1c1
protein product at the correct size as evident from the two controls: a control
Dyx1c1 plasmid and the tracheal lysate from Dyx1c1 wildtype mouse (Fig. 4-2a).

	
  

90

	
  

Figure 4-2: DYX1C1 protein is produced in the PCD patients. (a) Western blot
analysis shows DYX1C1 protein is expressed in the p.L19Q mutant condition at
48KDa. (b) Western blot analysis on the patient lysates shows that DYX1C1 is
expressed in the patients. (c) Quantification of the expression levels of DYX1C1
normalized to GAPDH. GAPDH was used as a loading control.

We obtained the respiratory epithelial cells of the patients and control from our
collaborators. These cells were pelleted and lysates were prepared according to
the procedures described in methods section of this chapter. Immunoblot
analysis on the patient lysates showed that Dyx1c1 protein was produced in the
patients and the Dyx1c1 protein band was observed at the correct molecular
weight of 48KDa compared to the control patient (Fig 4-2b). We also quantified
the abundance of DYX1C1 by normalizing the expression of DYX1C1 to that of
GAPDH (Fig. 4-2c). These results suggest that the Dyx1c1 protein produced in
the patients might be folded incorrectly that might affect its downstream
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interactions with other proteins.
4.3.2 Expression profile of axonemal dyneins and the known interactors of
Dyx1c1

Mutations in the cytoplasmic assembly factors lead to absence of the outer and
inner dynein arms in the mutant cilia. In some mutant cilia, these arms are
completely absent in the axoneme; whereas some others show a reduction in the
number of both outer and inner dynein arms. It is thought that the cytoplasmic
abundance of the axonemal dyneins might provide useful information on the
assembly of the dynein arms. Studies show that in case of a defect in the dynein
arm assembly, there is either a decrease or increase in the abundance of the
axonemal dyneins in the cytoplasm of the mutant compared to the control. The
chaperones work with the assembly factors to aid in the correct assembly of the
dynein motor complexes. However, due to defects in the assembly process, the
dynein arms do not get assembled and thus are not transported into the
axoneme of the cilia56,141.
We investigated the expression of the ODA intermediate chain subunit DNAI2
(Fig. 4-3a) and the IDA light intermediate chain subunit DNALI1 (Fig. 4-3a) in the
lysates obtained from the patient samples, using Gapdh as a loading control. It
was interesting to find that both the axonemal dynein subunits DNAI2 and
DNALI1 were reduced in the patients compared to the control (Fig. 4-3b). The
change in the axonemal dynein abundance was quantified by normalizing with
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GAPDH. The reduction in the abundance of the dynein subunits indicates a
defect in the preassembly of the axonemal dyneins in the cytoplasm or their
subsequent transport.

Figure 4-3: Reduction in the levels of the ODA subunit DNAI2 and IDA subunit
DNALI1 from the patients. (a) Western blot analysis performed using anti-DNAI2
and anti-DNALI1 exhibit reduction in the abundance of these subunits. GAPDH was
used as a loading control. (b) Quantification of the abundance of DNAI2 and DNALI1
normalized to GAPDH.

We have previously shown that Dyx1c1 interacts with an assembly factor
DNAAF2/ Ktu140, which is known to play a role in the assembly of the dynein
arms by acting as a co-chaperone and assisting in either folding or stabilization
of the dynein subunits. The dynein assembly is a multi-step process requiring the
axonemal dyneins, assembly factors and the chaperones. This is an orchestrated
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process wherein the interactions of all the components are critical for the dynein
arm generation. After the dynein arm is assembled, it is transported to the
Septin-containing transition zone where the quality control of the dynein arm is
performed. Our mass spectrometric results (described in Chapter 3) show that
Dyx1c1 interacts with one protein of the Septin family, Septin2. The entire
process of assembly and transport of the dynein arms is crucial for the ciliary
motility, and any defect in either of these processes can adversely affect the
function of cilia.
We investigated the expression profile of the above two interactors of Dyx1c1,
Ktu and Sept2, to assess for their altered abundance in the Druze patient
samples. Intriguingly, we found that both Ktu and Sept2 were expressed at the
same levels in the patients compared to the control and were detected at the
correct size (Fig 4-4a,b).

Figure 4-4: Expression profile of SEPTIN2 and KTU in the patient samples.
Western blot analysis of the patient samples using anti-SEPT2 (a) and anti-KTU (b)
antibodies show that the levels of these proteins are unchanged in the patients
compared to the control. GAPDH was used as a loading control.
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4.3.3 Interaction analysis of Dyx1c1 with known interactors
Our results suggest that the Dyx1c1 protein in the Druze patient population is
probably misfolded that could potentially alter the interactions of Dyx1c1 with
other proteins in turn affecting the assembly of the dynein arms. We hence
investigated the interactions of Dyx1c1 mutant construct with its previously
identified interactors Ktu and Sept2 in heterologous expression system. These
proteins are known to function in ciliogenesis and/or dynein assembly and
transport. We co-transfected HEK cells with either the myc-tagged wildtype or
mutant construct of Dyx1c1 along with flag-tagged Sept2 or Ktu. We performed
immunoprecipitation experiments using anti-Dyx1c1 antibody to pull down
Dyx1c1 and probed for either Sept2 or Ktu. Even though the expression levels of
Ktu and Sept2 in the patients were not altered, we found that the interaction of
Dyx1c1 with Sept2 and Ktu was reduced in the mutant condition compared to the
control (Fig 4-5a,b).
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Figure 4-5: Interaction of DYX1C1 with SEPT2 and KTU is reduced in the mutant
condition. (a) Co-immunoprecipitation and western blot analysis shows weaker
interaction of DYX1C1-p.L19Q-myc and SEPT2 compared to the control DYX1C1myc condition. (a) Co-immunoprecipitation and western blot analysis shows weaker
interaction of DYX1C1-p.L19Q-myc and KTU compared to the control DYX1C1-myc
condition. (c) Quantification of interaction of SEPT2 and KTU with DYX1C1
normalized to the immunoprecipitated DYX1C1. Student’s T-test, P-value <0.05 (**);
P-value <0.001 (***).
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In order to quantify the interaction of Dyx1c1 and Ktu or Sept2, we first got the
percentage ratio of the intensity of Sept2 or Ktu in the immunoprecipitates to the
intensity of Sept2 or Ktu in the input and then normalized that to the percentage
of Dyx1c1 protein that was immunoprecipitated. We found a 60% reduction in the
interaction of Dyx1c1 to Sept2 in the mutant condition compared to the control;
while the interaction of Dyx1c1 to Ktu exhibited a 75% decrease in the interaction
(Fig. 4-4c). Thus, we speculate that the Dyx1c1 function in the cilia is probably
mediated by its interactions with Ktu and Sept2. These proteins constitute a
group of proteins of the ciliary cytoplasm; hence it strengthens our hypothesis
that Dyx1c1 functions as a cytoplasmic assembly factor.

4.4 Discussion

In the present study, a novel mutation in Dyx1c1 (p.L19Q) that is causative of
PCD in humans is characterized. The Dyx1c1 gene is conserved among mice,
zebrafish and humans. Dyx1c1 is identified as a protein essential for the motility
of cilia; the absence of which leads to absence of inner and outer dynein arms in
the ciliary axoneme. The phenotypic similarity of the Dyx1c1 mutants in three
organisms examined suggests that Dyx1c1 functions for dynein arm preassembly. We initially assessed whether the Dyx1c1 protein was produced in the
nasal respiratory epithelial cells of the patients harboring this mutation.
Intriguingly, we found that Dyx1c1 protein was expressed in the patients at the
appropriate molecular weight (48KDa). The plasmid construct with this mutation,
when transfected into HEK cells also expressed the DYX1C1 protein.
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Ciliary axonemes of the PCD patients with this mutation exhibited a loss of the
outer and inner dynein arms. The mutant cilia lacked the expression of the ODA
heavy chain DNAH5 as well as the IDA light intermediate chain DNALI1 in the
axoneme. We characterized the protein expression levels of the ODA and IDA
subunits DNAI2 and DNALI1 respectively in the patient samples and observed
reduced abundance of these two proteins in the mutant samples compared to the
control. Densitometric analysis exhibited a 72% reduction in the expression of
DNAI2, while a 99% decrease in DNALI1. The reduction in the abundance of the
axonemal dynein subunits has been implicated in a faulty assembly of the dynein
arms in the mutant cilia due to the loss of the subunit incorporation into the
dynein motor complex or altered rates of degradation. We thus gathered
additional evidence of the role of DYX1C1 in the cytoplasmic preassembly of the
ciliary dyneins due to the reduction in the subunit abundance.
Our biochemical analyses provided additional insight into the proposed function
of Dyx1c1 as a facilitator of dynein pre-assembly, by revealing defects in the
association of mutant Dyx1c1 with Sept2 and Ktu. The finding of reduced ODA
intermediate chain and IDA light intermediate chain abundance in the mutant is
consistent with an altered pre-assembly process. Intriguingly, no change in the
expression pattern of Sept2 and Ktu was observed in the mutant when compared
to the wildtype. Furthermore, immunoprecipitation demonstrated an interaction
between Dyx1c1 and Ktu as well as Sept2 in the control condition however, a
substantial reduction in the interaction was observed in the mutant condition.
Because Hsp70 and Hsp90 were found to be interacting proteins of Dyx1c1 and
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Ktu, Dyx1c1 could work as a co-chaperone to localize general functions of
molecular chaperones (holding, assembling and protecting of proteins from
degradation) to dynein arm formation with the help of Ktu. The reduced
interaction might implicate decreased transfer of the correctly assembled dynein
arms in to the axoneme. Although much progress has been made in
understanding the mechanisms of IFT responsible for the transport of the dynein
arms, very little is known about the cytoplasmic process for pre-assembly of
dynein complexes. Dyx1c1 point mutant will thus aid in understanding this
cytoplasmic process.

4.5 Methods:
4.5.1 Protein lysates for human respiratory epithelial cells
Human respiratory cells were obtained by nasal brushing. The suspension
containing the nasal respiratory cells were centrifuged at 20,000xg at 4oC for 10
min to pellet the cells. The cells were then washed 2 times with PBS to remove
any mucus or storage buffer. The cells were again centrifuged 20,000xg at 4oC
for 10 min and the pellet was incubated in RIPA lysis buffer containing protease
inhibitor cocktail. The lysates were incubated on ice for 20 min, following which
the lysates were spun down to pellet the debris. The concentration of the protein
lysates was obtained by BCA assay.
4.5.2 Plasmids
The DYX1C1-WT and DYX1C1-p.L19Q plasmids were obtained from Dr. Hannah
Mitchision. DYX1C1-WT and DYX1C1-p.L19Q sequences were further amplified
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using primers incorporating myc epitope tagged sequence and then subcloned
into pCAG vector to create pCAG- DYX1C1-WT-myc and pCAG-DYX1C1p.L19Q-myc plasmids. The Sept2-flag plasmid was constructed as described
previously (Chapter 3). The flag-tagged DNAAF2 plasmid was a gift from Dr.
Heymut Omran. The sequence of all plasmids was confirmed by sequencing.
4.5.3 Cell culture and transfection
Human embryonic kidney (HEK293T) cells were grown to confluence in DMEM
supplemented with 10% FBS, 1% non-essential amino acid (NEAA) and 1%
penicillin-streptomycin antibiotics (Invitrogen). Cultures were plated at a density
of 106 cells on a 10-cm petridish. DNA (24 µg) was added to the petridish with 75
µl of Lipofectamine 2000 reagent (Invitrogen) in OptiMEM-1. The transfection mix
was added to cells in normal growth media and incubated for 48 h at 37 °C. To
obtain the protein lysates from the cells, the normal growth media was removed
and the cells were washed with PBS. The cells were then collected, centrifuged
to pellet the cells and the pellet was incubated in RIPA buffer supplemented with
1X Proteinase Inhibitor Cocktail for 20 min on ice. The lysates were then
centrifuged at 2000xg to pellet the debris. Protein blots were also performed on
the transfected cells as described above.
4.5.4 Western blotting
Proteins were separated on 10% SDS-PAGE minigels and then transferred to
Immobilon (Millipore) membrane for protein blotting. For detecting DYX1C1
protein, the antibody to N-terminal DYX1C1 (Sigma, SAB4200128) was used at a
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dilution of 1:200; antibody to GAPDH (Sigma, G8795) was used at a 1:1,500
dilution as a loading control; monoclonal antibody to DNAI2 (Abnova, M01, clone
1C8; 1:500 dilution), c-myc antibody (Sigma, C3956, 1:500 dilution), c-myc
antibody mouse monoclonal (Sigma, M4439, 1:750 dilution), antibody to flag
produced in rabbit (Sigma, SAB1306078, 1:1000 dilution), and mouse
monoclonal anti-flag antibody (Sigma, F4042, 1:500 dilution). LI-COR Odyssey
infrared secondary antibodies (goat antibody to mouse 680 (926-32220), goat
antibody to mouse 800 (926-32210) goat antibody to mouse 680 (926-32221)
and goat antibody to mouse 800 (926-32211)) were used at dilutions of 1:10,000.
All blots were imaged and analyzed using a LI-COR Odyssey Scanner and
Software.

4.5.5 Immunoprecipitation
Immunoprecipitation assays were performed using the Dynabeads Protein G
Immunoprecipitation kit (Invitrogen). Briefly, Dynabeads were resuspended in the
vial and separated on a magnet from solution. Antibody to Dyx1c1 (Sigma,
SAB4200128), (5 µg) was diluted in 200 µl of Washing and Binding Solution and
incubated with rotation for 120 min at room temperature. Bead-antibody
complexes were separated on the magnet, washed by gentle pipetting and
separated. Protein lysates were incubated with the bead-antibody complexes
overnight at 4 °C. Bead-antibody-antigen complexes were then washed using the
washing solution three times. Complexes were then incubated with elution buffer
for 10–15 min to dissociate them. Beads were separated on a magnet, and
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supernatant containing the proteins was separated by SDS-PAGE and analyzed
by protein blotting using monoclonal antibody to antibody to flag produced in
rabbit (Sigma, SAB1306078, 1:1000 dilution), and mouse monoclonal anti-flag
antibody (Sigma, F4042, 1:500 dilution). Rabbit IgG was used as a control.
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5. DYX1C1 (DNAAF4) IS REQUIRED FOR ASSEMBLY OF
LIGHT AND INTERMEDIATE CHAIN AXONEMAL
DYNEINS IN TRACHEAL EPITHELIAL CELLS
5.1 Abstract:
Genetic evidence indicates that cytoplasmic preassembly of axonemal dyneins
requires proteins encoded by the genes DNAAF1/LRRC50, DNAAF2/KTU,
DNAAF3 and DYX1C1/DNAAF4. These assembly factors are thought to act as
co-chaperones that promote the assembly of large macromolecular axonemal
dynein complexes in the cytoplasm prior to transport into the cilia. In this study,
we have investigated the role of Dyx1c1 in preassembly of components of the
outer dynein arm (ODA) complex. Dyx1c1 interacts with intermediate and light
chain subunits of the ODA complex in the cytoplasm of tracheal epithelial cells.
Light and intermediate chains fail to form complexes in the cytoplasm of tracheal
epithelial cells of Dyx1c1 mutants. Dyx1c1 increases by four fold the association
of Light chain subunits Dnal1 and Dnal4 in heterologously expressing HEK 293-T
cells. Finally, a novel Primary Ciliary Dyskinesia (PCD) patient associated
missense mutation in Dyx1c1 is impaired in its ability to assembly Dnal1 and
Dnal4. In conclusion, we identify a step in ODA pre-assembly in which Dyx1c1
facilitates formation of light and intermediate chain dynein complexes.

5.2 Introduction:
Failure to assemble the outer and inner dynein arms of motile cilia causes
Primary Ciliary Dyskinesia (PCD), a ciliopathy characterized by defects in
multiple organ systems. The axonemal dynein assembly factors identified largely
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through genetic studies have been classified into three general categories: i)
cytoplasmic proteins required for the preassembly of outer and inner dynein
complexes

(e.g.

DNAAF1,

DNAAF2,

DNAAF3

and

DNAAF4/DYX1C1)102,104,138,140; ii) adaptor proteins involved in the transport of the
assembled 2MDa dynein motor complex (ODA16)58,62; and iii) proteins of the
axoneme that assist in the docking of the assembled dynein arms to the
microtubular scaffold at appropriate sites (e.g. DC)106,151,152. The molecular
details of axonemal dynein assembly, especially the stages in the cytoplasmic
preassembly process, that each of the DNAAF proteins serve is not yet
completely defined.
The outer dynein arms (ODAs) of motile cilia are composed of either two (e.g.
mammals and sea urchins) or three (e.g. Chlamydomonas and Tetrahymena)
dynein heavy chain (HC) molecules; two WD-repeat intermediate chains (ICs)
and multiple light chains (LCs)32,33,36,58. In Chlamydomonas, one distinct type of
ODA complex is known to contain three HCs (alpha, beta and gamma-HC), two
ICs, nine LCs and three docking complex proteins. Based on homolog searches,
five ODA HC orthologs of Chlamydomonas beta and gamma chains have been
identified in humans. In humans and mice DNAI1, DNAI2 and TXNDC3 are the
three known IC subunits, and DNAL1, TCTE3, DYNLRB1/2, DYNLL1/2,
DYNLT1/2 and DNAL4 form the group of LC subunits of the ODA. Genetic
studies have shown that mutations in several ODA complex dynein subunits
cause PCD: i) DNAI1153, OMIM ID: 604366, ii) DNAH5154, OMIM ID: 603335, iii)
DNAH1192, OMIM ID: 603339, iv) thioredoxin domain containing 395 (TXNDC3,
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OMIM ID: 607421), v) DNAI293, OMIM ID: 605483 and vi) DNAL1155, OMIM ID:
610062. Mutations in DNAI1, DNAI2, DNAL1 and DNAH5 cause an ODA
deficiency in PCD patients leading to ciliary immotility. In contrast, DNAH11
mutations did not result in ultrastructural defects in cilia and TXNDC3 mutant cilia
exhibited both normal and ODA-deficient cross sections. TXNDC3 is proposed to
function as one of the two distinct ODAs in humans.
Cytoplasmic preassembly of the ODA complex is thought to be a sequential
process wherein the intermediate chain subunits first assemble, followed by
assembly of the heavy chain subunits, and finally light chains are incorporated to
form a functional ODA motor complex that is competent for attachment to the
ciliary doublet microtubules. The docking complex comprising 3 proteins helps
assemble the motor complex on the doublet microtubules. In addition to the
individual dynein chain, the process requires both chaperones and the
specialized assembly factors, DNAAFs56,156. Mutations in most dynein chains
interfere with the association of the remaining subunits into a complex in the
cytoplasm and block subsequent transport of this complex into the axoneme.
Mutations identified in assembly factors (DNAAF1/Lrrc50, DNAAF2/Ktu, DNAAF3
and DNAAF4/Dyx1c1) lead to the absence of ODAs from the mutant axoneme
due to a faulty assembly of the ODA motor complex in the mutant cytoplasm. A
mutation in the assembly factor DNAAF1/Lrrc50/Oda7, a leucine-rich repeat
protein that localizes to the cell body, caused decrease in the abundance of one
of the heavy chain subunits in the cytoplasm without affecting levels of other
heavy chains and intermediate chain subunits. A partial co-assembly of the
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remaining heavy and the intermediate chains was observed in Oda7
mutants58,157,158. Ktu/PF13/DNAAF2, a cytoplasmic assembly factor belonging to
the PIH protein group, is hypothesized to act as a co-chaperone in dynein
assembly within the cytoplasm as it interacts with Hsp70. Studies show that all
three ODA heavy chain subunits are depleted from pf13 mutants, while the
intermediate chains are overabundant. Immunoprecipitation experiments show
that intermediate and light chains preassemble in the pf13 mutants, however
heavy chains are not assembled suggesting that KTU may be involves in heavy
chain assembly but not light and intermediate chain assembly60,61,156. A third
dynein assembly factor DNAAF3/Pf22 is specifically required for the proper
folding of the individual HCs for their subsequent association into larger, multisubunit complexes with the ICs and LCs46,102. DNAAF1, DNAAF2 and DNAAF3
thus appear to facilitate folding of the dynein heavy chains that are then
assembled into an ODA complex in the presence of chaperones. Factors that
similarly contribute to assembly of light and intermediate chains have yet to be
defined.
Mutations in Dyx1c1 are identified that cause PCD in humans and PCD-like
phenotypes in mouse and zebrafish. Immunofluorescence analysis revealed that
Dyx1c1 localizes to the cytoplasm of mouse respiratory epithelial cells. DYX1C1
interacts with the E3 ubiquitin ligase CHIP, HSP70, HSP90, and KTU/DNAAF2
consistent with function as a cytoplasmic assembly factor128,129. Together, these
findings suggested that DYX1C1/DNAAF4 is an essential component of the
ciliary dynein cytoplasmic pre-assembly process159. Dyx1c1 mutant ciliary
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axoneme exhibit the lack of the ODA components DNAH9, DNAH5 and
DNAI2160; but the assembly state of heavy, light and intermediate chain dyneins
in the cytoplasm of the Dyx1c1 mutants has not been previously defined.
In this study we provide evidence that DYX1C1 promotes assembly of axonemal
light chains in the cytoplasm of tracheal epithelial cells. We find that Dyx1c1
interacts with the ODA intermediate chain subunits Dnai1 and Dnai2 and light
chain subunits Dnal1 and Dnal4 in tracheal epithelial cells. Tracheal epithelial
cells in mutants have reduced levels of light and intermediate chains, and light
and intermediate chains fail to assemble in mutants. To further test whether
DYX1C1 specifically promotes assembly of light chains we co-expressed
DYX1C1 or other DNAAFs in HEK293 cells along with axonemal dynein light
chains. DYX1C1 promoted the highest level of light chain association in Hek293
cells compared to all other DNAAFs, and this activity was reduced by DYX1c1
mutations. Based on this data, we propose a model wherein Dyx1c1 assembles
the light chain subunits Dnal1 and Dnal4 in an early step in ODA preassembly.

5.3 Results:
5.3.1 Dyx1c1 interacts with axonemal dynein subunits of the ODA complex
in the cytoplasm of tracheal epithelial cells
Previous studies have suggested that mutations in dynein assembly factors could
either prevent the dynein arm complex from preassembling in the cytoplasm and
that dynein assembly factors might play a role in the assembly of the dynein
subunits; either by directly interacting with them, or in an indirect, chaperone-
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mediated fashion. More direct biochemical analysis of Dyx1c1 function depends
on the cytoplasmic pool of the axonemal dyneins. In order to identify the role of
Dyx1c1 in the cytoplasm, we developed a protocol for separation of the ciliary
axonemes from the trachea of Dyx1c1 wildtype and knockout mouse. We thus
obtain two fractions after the deciliation workflow: i) cytoplasmic fraction
containing the trachea stripped off the ciliary axoneme and ii) axonemal fraction
consisting of the ciliary axoneme. We found that the wildtype and knockout
axonemal fraction had little or no contamination of the cytoplasmic fraction and
vice-versa.
We investigated the role of Dyx1c1 in the ODA pre-assembly in the tracheal
cytoplasm. Since some of the assembly factors associate with one or more of the
axonemal dynein subunits themselves, we found it important to evaluate for an
interaction of Dyx1c1 with the intermediate and light dynein chain subunits of the
outer dynein arm complex (Fig. 5-1). We investigated the interaction of Dyx1c1
with the dynein subunits in the cytoplasmic fraction obtained from the WT and
KO trachea. We performed immunoprecipitations using the anti-Dyx1c1 antibody
to pull down the Dyx1c1 protein from the wildtype and knockout Dyx1c1 tracheal
cytoplasmic fractions. Since the Dyx1c1 protein is not expressed in the KO
mouse trachea, the immunoprecipitation from the KO cytoplasm acts as the
control. We looked for the interaction of Dyx1c1 with the ODA light chain subunits
Dnal1 and Dnal4; and found that Dyx1c1 interacts with both the dynein light
chain subunits Dnal1 and Dnal4. When we tested for the interaction of the
Dyx1c1 with the intermediate chain subunits of the ODA Dnai1, Dnai2 and
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Txndc3, we found that Txndc3 does not co-immunoprecipitate with Dyx1c1.
However, the two other dynein intermediate chain subunits Dnai1 as well as
Dnai2 co-precipitate with Dyx1c1 (Fig. 5-1). We thus show that Dyx1c1 needs to
associate with intermediate and light chain dynein subunits for its function as a
dynein cytoplasmic assembly factor.

Figure 5-1 Interaction of Dyx1c1 with intermediate and light chain subunits of
the outer dynein arm. Co-immunoprecipitation and western blot analysis indicates
that Dyx1c1 interacts with ODA light chains Dnal1 and Dnal4; ODA intermediate
chains Dnai1 and Dnai2; but not with Txndc3.

5.3.2 Dyx1c1 require C-terminal TPR containing domains to interact with
ODA light chains Dnal1 and Dnal4
We assessed the interactions of Dyx1c1 with the ODA light chains Dnal1 and
Dnal4 in a heterologous expression system. The Dyx1c1 protein has an Nterminal p23 domain similar to the heat shock protein family domains and Cterminal TPR domains that are known to mediate protein-protein interactions.
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Biallelic mutations identified in Dyx1c1 that caused PCD in humans were found
between amino acids 128 and 195 of the 420-amino acid Dyx1c1 protein. These
mutations are thus predicted to lead to a truncated protein product devoid of the
TPR domains. Studies characterizing the role of Dyx1c1 in the developing rat
neocortex showed that knockdown of Dyx1c1 leads to abnormal neuronal
migration and this phenotype can be rescued by overexpressing the TPR
domain-containing region of Dyx1c1. Additionally the TPR domains have been
shown to be important for interaction of Dyx1c1 with the chaperones.
We tested three Dyx1c1 constructs fused with GFP; one full-length; one Nterminal deletion missing the p23 domain; and the other C-terminal deletion
construct lacking the TPR domains; as shown in the schematic in Fig. 5-2a for
the interaction with Dnal1 and Dnal4 by co-immunoprecipitation. Dnal1 and
Dnal4 were incorporated into the vector with chicken actin gene promoter with
flag and myc epitope-tags (pCAG-Dnal1-flag and pCAG-Dnal4-myc) respectively.
To test for the interaction of Dyx1c1 with the light chains Dnal1 and Dnal4, we
co-transfected HEK 293T cells with full-length Dyx1c1 (pCAG-Dyx1c1-GFP)
construct with either pCAG-Dnal1-flag or pCAG-Dnal4-myc. We also cotransfected either of the light chains with pCAG-GFP plasmid as a control. We
immunoprecipitated the Dyx1c1 protein using the anti-GFP antibody and probed
with Dnal1 or Dnal4 antibody. We found that Dyx1c1 interacts with Dnal1 and
Dnal4 both independently co-precipitate with Dyx1c1 (Fig. 5-2b, d). We found a
9-fold increase in the interaction between Dnal1 and Dyx1c1, whereas a 5-fold
increase was observed in the association of Dnal4 and Dyx1c1 compared to the
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GFP control condition. We further investigated the interaction of the Dnal1 and
Dnal4 with the truncation constructs of Dyx1c1. We co-transfected the dynein
light chains Dnal1 or Dnal4 with one of the following: full-length, N-terminal or Cterminal

truncation

constructs

of

Dyx1c1.

We

then

performed

immunoprecipitation experiments using anti-GFP antibody and probed for Dnal1
or Dnal4 (Fig 5-2c, e). The interaction of both Dnal1 and Dnal4 with the p23
domain of Dyx1c1 was reduced by about 75% when normalized to their
association with full-length Dyx1c1. Interestingly, both the Dnal1 and Dnal4 were
found to co-precipitate with the TPR domain-containing construct of Dyx1c1. The
TPR domains of Dyx1c1 are thus necessary and sufficient for the interaction of
Dyx1c1 with the light chain dyneins Dnal1 and Dnal4.
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Figure 5-2: Heterologous interaction of Dyx1c1 with ODA light chain subunits
Dnal1 and Dnal4. (a) Schematic of Dyx1c1 full-length and truncation constructs
fused to GFP. Co-immunoprecipitation and western blot analysis shows that Dyx1c1
interacts with Dnal1 (b) and Dnal4 (d). Co-immunoprecipitation and western blot
analysis shows that Dyx1c1 interacts with Dnal1 (c) and Dnal4 (e) through the TPR
domains of Dyx1c1.
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5.3.3 Light and intermediate dynein subunits of the ODA complex fail to
assemble in the Dyx1c1 knockout tracheal epithelial cell cytoplasm

The mutant cilia of the previously identified axonemal dynein assembly factors
(DNAAF1, DNAAF2, DNAAF3) have all shown absence of the outer and inner
dynein arms in the axoneme due to a defect in the chaperone-dependent
cytoplasmic preassembly of the ODA or IDA complex. Since Dyx1c1 localizes to
the cytoplasm of the ciliated respiratory epithelial cells and interacts with the heat
shock proteins Hsp70 and Hsp90, it is hypothesized to play a role in promoting
axonemal dynein subunit preassembly. We thus investigated the assembly state
of the ODA complex in the cytoplasm of the Dyx1c1 knockout trachea. To assess
the association of the light chain subunits Dnal1 and Dnal4, we coimmunoprecipitated the light chain subunit Dnal1 using anti-Dnal1 antibody and
probed for Dnal4 as well as Dnal1. We found that Dnal4 co-precipitated with
Dnal1 in the WT cytoplasm, while it failed to interact in the KO cytoplasm. In
order to evaluate the interaction of Dnal1 to Dnal4 quantitatively, we analyzed the
percentage intensity ratio of immunoprecipitated Dnal4 to its input and
normalized that to the percentage intensity ratio of immunoprecipitated Dnal1 to
its input. The interaction between Dnal1 and Dnal4 was reduced by ~85% in the
knockout cytoplasm indicating a faulty assembly of the light chain subunits (Fig.
5-3a).
We further assessed the interaction amongst the intermediate chain subunits of
the ODA complex for which we immunoprecipitated one of the IC subunits and
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blotted for the presence of the other IC subunit. Here we investigated the
interaction between the IC subunits Dnai1 and Dnai2 as well as Txndc3 and
Dnai2. We immunoprecipitated the IC subunit Dnai2 from the WT and KO
cytoplasmic extracts and probed with Dnai1 and Txndc3 to analyze their
interaction with Dnai2. Dnai1 and Dnai2 interact in the WT cytoplasm while this
interaction is diminished in the KO cytoplasm. After quantitative analysis of the
interaction of Dnai1 and Dnai2 as previously described, we identified that
interaction was reduced to ~1% in the KO cytoplasm compared to the 34%
association in the WT cytoplasm (Fig. 5-3b). Txndc3 and Dnai2 were found to
assemble in the WT cytoplasm and failed to associate in the KO. The interaction
between these two subunits was reduced by almost 99% in the KO cytoplasm
when compared to the WT (Fig. 5-3c). We have shown that Txndc3 fails to
associate with Dyx1c1 (Fig. 5-1d) but the interaction of Txndc3 with the
intermediate chain subunit Dnai2 is altered in the mutant cytoplasm. Dyx1c1
seems to be crucial for the interaction of the intermediate chain subunits Dnai1,
Dnai2 and Txndc3 in the cytoplasm, even though it does not directly interact with
Txndc3.
Next, we examined the assembly state of the LC-IC complex of the ODA by
assessing the interaction between IC subunit Dnai2 and LC subunit Dnal4. We
performed immunoprecipitation of Dnal4 using anti-Dnal4 antibody from the WT
and KO cytoplasmic extracts and probed for Dnai2. Dnai2 co-precipitated with
Dnal4 in the WT cytoplasm, but showed reduced association in the KO
cytoplasm. Upon quantitative analysis of the interaction, we found a 76%
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decrease in the association of Dnai2 to Dnal4 in the KO (Fig. 5-3d). These
results demonstrate the defect in the assembly of the light chain subunits with the
intermediate chain subunits in the Dyx1c1 mutant cytoplasm. We thus found that
Dyx1c1 is critical for the assembly of the ODA light chain and intermediate chain
dynein subunits in the cytoplasm.
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Figure 5-3: Outer dynein arm fails to assemble in the Dyx1c1 knockout tracheal
cytoplasm. (a) Co-immunoprecipitation and western blot analysis shows that Dnal4
interacts with Dnal1 (top panel); quantification of interaction (bottom panel). (b) Coimmunoprecipitation and western blot analysis shows that Dnai1 interacts with Dnai2
(top panel); quantification of interaction (bottom panel). (c) Co-immunoprecipitation
and western blot analysis shows that Txndc3 interacts with Dnai2 (top panel);
quantification of interaction (bottom panel). (d) Co-immunoprecipitation and western
blot analysis shows that Dnai2 interacts with Dnal4 (top panel); quantification of
interaction (bottom panel).
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5.3.4 Dyx1c1 induces the assembly of axonemal light chain subunits of
Dnal1 and Dnal4
We have shown earlier in Fig. 5-3a that the dynein light chain subunits Dnal1 and
Dnal4 interact in the wildtype cytoplasm and this interaction is weakened in the
Dyx1c1 KO cytoplasm. To obtain an insight into the function of Dyx1c1 pertaining
to light chain assembly, we tested for the association of Dnal1 and Dnal4 in HEK
cells. HEK cells are immortalized kidney derived cell line that possesses primary
cilia. Since HEK 293-T cells do not normally express the axonemal dyneins or
motile-cilia specific genes, it was interesting to evaluate whether Dyx1c1 would
be sufficient for the association of Dnal1 and Dnal4 in these cells. We cotransfected HEK cells with pCAG-Dnal1-flag and pCAG-Dnal4-myc with pCAGDyx1c1-GFP or pCAG-GFP constructs. We then performed immunoprecipitation
using anti-Dnal1 antibody to pull down the Dnal1 and its interacting proteins and
probed with Dnal4, to test for Dnal1-Dnal4 interaction. We also probed the blots
for Dnal1 for normalization and subsequent analysis of the association. In the
absence of full-length Dyx1c1, Dnal1 and Dnal4 fail to assemble heterologously;
interestingly Dnal1 and Dnal4 interact robustly in the presence of Dyx1c1 (Fig. 54a). To obtain a quantitative measure of the interaction, we acquired percentage
of intensity ratio of immunoprecipitated Dnal4 to its wildtype expression level and
normalized that to the intensity ratio of immunoprecipitated Dnal1 to its wildtype
expression level. We observed that there was a 8-fold increase in the association
of Dnal1 and Dnal4 in the presence of Dyx1c1 compared to the GFP control
condition (Fig. 5-4b).
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We showed that the C-terminal TPR-containing domains of Dyx1c1 mediate the
interaction Dyx1c1 with the individual axonemal dynein light chain subunits Dnal1
and Dnal4. To assess the domain of Dyx1c1 required for the association of Dnal1
and Dnal4, we co-transfected with both pCAG-Dnal1-flag and pCAG-Dnal4-myc
constructs with either N-terminal or C-terminal truncation constructs of Dyx1c1.
Using the anti-Dnal1 antibody, we pulled down Dnal1 protein and performed
western blot to look for the expression of Dnal4. Unexpectedly, we found that
Dnal1 and Dnal4 associate with each other in both the conditions (Fig. 5-4a) and
just the TPR-domains are not sufficient for the assembly. Compared to the fulllength Dyx1c1, the Dnal1-Dnal4 association was reduced to half in the presence
of the Dyx1c1 truncation constructs (Fig. 5-4b); indicating that both the domains
of Dyx1c1 are required for the light chain assembly.
We further investigated whether the interaction of Dnal1 and Dnal4 was altered in
the presence of the novel missense mutant Dyx1c1 p.L19Q (Dyx-Mut). We cotransfected HEK cells with the pCAG-Dnal1-flag and pCAG-Dnal4-myc along
with point mutant construct Dyx-Mut. We then performed co-immunoprecipitation
experiments and analysis as described earlier and found that the association of
Dnal1 and Dnal4 was considerably reduced in the Dyx-Mut condition (Fig. 5-4a).
Analysis of the Dnal1-Dnal4 assembly in the mutant condition exhibited a
reduction of 62.5% when compared to the full-length Dyx1c1 condition (Fig. 5-4b).
We next assessed whether any of the other three cytoplasmic assembly factors
DNAAF1/Lrrc50, DNAAF2/Ktu and DNAAF3 could aid in the association of the
light chains Dnal1 and Dnal4. HEK cells were co-transfected with pCAG-Dnal1	
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flag and pCAG-Dnal4-myc along with one of the above-mentioned assembly
factors. After the co-immunoprecipitation and western blot analysis, we found
that Dnal1 and Dnal4 do not associate in the presence of DNAAF1 or DNAAF3.
Interestingly, they are found to interact in the presence of the assembly factor
DNAAF2 (Fig. 5-4a), which is previously shown to interact with Dyx1c1. When
normalized to Dnal1-Dnal4 assembly in the presence of full-length Dyx1c1, it was
observed that the association was decreased by 50% in the presence of
DNAAF2/Ktu (Fig. 5-4b). We thus show that Dyx1c1 induces the assembly of the
dynein light chain subunits Dnal1 and Dnal4 in a heterologous expression system.
We conclude that both the TPR and p23 domains of Dyx1c1 are required for the
promoting the assembly of the light chain subunits.
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Figure 5-4: Dyx1c1 facilitates the assembly of Dnal1 and Dnal4. (a) Interaction of
Dnal1 and Dnal4 in the presence of full-length Dyx1c1, truncation constructs of
Dyx1c1, Dyx-Mut and assembly factors DNAAF1, DNAAF2 and DNAAF3. (b)
Quantification of the association of Dnal4 to Dnal1 when normalized to Dnal1.
Posthoc analysis, P-value<0.001 (***).
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5.4 Discussion
Defects in the assembly of the outer and inner dynein arm complexes due to
mutations in either the dynein subunits themselves, or the assembly factors that
aid in the formation of the dynein complexes, lead to PCD. It has been proposed
in previous studies performed in Chlamydomonas that the dynein arms are
preassembled in the cytoplasm as three complexes: a heavy chain-intermediate
chain (HC-IC) complex; a light chain complex (LC) and a docking complex (DC)56.
According to this model, the heavy and the intermediate chain subunits exist as a
complex in the cytoplasm and the lack of either the heavy or light chain subunit
would lead to a defective dynein complex. The light chains would then be
assembled onto the HC-IC complex, which would later be docked on the DC
before being loaded on the IFT particle. Detailed characterization of the
cytoplasmic preassembly process is required to understand ciliary motility that
might help in the better diagnosis of PCD. Deciphering the multi-step assembly
pathway and the proteins involved could also potentially lead to identification of
pharmacological targets that might help PCD patients.
Dyx1c1 has been previously identified as a cytoplasmic pre-assembly factor of
the axonemal dyneins, the lack of which leads to the absence of both the inner
and the outer dynein arms in the axoneme of the patients. Despite the functional
conservation of Dyx1c1 amongst the organisms examined (mouse, humans and
zebrafish) evident from the similar phenotypes observed, it was still unclear how
Dyx1c1 functions in the dynein arm assembly process. It was hypothesized that
due to the cytoplasmic localization of Dyx1c1, it plays a role in the assembly of
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the dynein arm complex through its interactions with the heat shock proteins
and/or its subsequent transport from the cytoplasm to the transition zone or the
base of the cilia. The data presented in this study suggest that the assembly of
the outer dynein arm complex requires at least the following steps: a first step in
which the subunits are folded and stabilized; a second step wherein the subunits
are aggregated by one or more assembly factors; and the final step that
generates a functional complex competent for transport and binding to the
microtubules.
Our biochemical analyses provide an important insight into the proposed function
of Dyx1c1 as a facilitator of dynein preassembly in the cytoplasm by identifying
the defect in the assembly of the dynein light and intermediate chain subunits in
the absence of Dyx1c1. It has been shown that the assembled dynein arms form
a pool of cytoplasmic precursor that is then transferred to a loading zone around
the basal body from where it is transported into the axoneme via IFT. Since the
dynein arm assembly process takes place in the cytoplasm, it was critical to
perform fractionation of the trachea into cytoplasmic extract and axonemal
extract. We evaluated the interaction of Dyx1c1 with the light and intermediate
chain dynein subunits by co-immunoprecipitation and western blot analysis. We
found that Dyx1c1 fails to interact with IC subunit Txndc3, but associated with the
other IC chains Dnai1 and Dnai2 as well as LC subunits Dnal1 and Dnal4. The
interaction of Dyx1c1 with the IC and LC subunits is considerably reduced in the
Dyx1c1 KO tracheal cytoplasm; thus indicating that Dyx1c1 is important for the
assembly of the intermediate and light chain axonemal dynein subunits in the
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cytoplasm. We also verified the interaction of the light chain subunits Dnal1 and
Dnal4 with Dyx1c1 heterologously. Furthermore, we identified that the TPR
domains of Dyx1c1 are critical for the light chain interaction.
We found that the ODA complex fails to assemble in the Dyx1c1 mutant
cytoplasm. We observed that the light chain subunits Dnal1 and Dnal4 that
associated in the WT cytoplasm fail to assemble in the KO cytoplasm. Similarly,
the IC subunits Dnai2 and Dnai1 as well as Dnai2 and Txndc3 that interact in the
WT cytoplasm are found to not assemble in the KO cytoplasm. Interestingly, the
IC-LC assembly of Dnai2 and Dnal4 was also absent in the mutant cytoplasm
indicating a role of Dyx1c1 in the assembly of the IC-IC, LC-LC as well as IC-LC
subunits of the ODA complex. We also observed reduced abundance of the light
and intermediate chain subunits in the Dyx1c1 knockout cytoplasm, which is
consistent with an altered preassembly process. Since the light chain subunits
Dnal1 and Dnal4 interact with each other in the Dyx1c1 wildtype cytoplasm, we
assessed whether Dyx1c1 was sufficient for their association in HEK cells.
Interestingly, Dyx1c1 induces the assembly of Dnal1 and Dnal4 and the
association of these two light chains requires both the p23 and TPR domains of
Dyx1c1. A novel missense mutation identified in Dyx1c1 reduces the interaction
between the light chains by about 60%. Previous evidence has also shown that
in spite of the overabundance of one the heavy chain dynein subunits in the
cytoplasm of the Ktu mutant, this subunit fails to co-precipitate with the other
dynein subunits, suggesting an aberrant assembly process61. We also tested the
interaction of Dnal1-Dnal4 in the presence of Ktu, an interactor of Dyx1c1, as
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well as the other assembly factors Dnaaf1 and Dnaaf3. The association of the
light chains was impaired in the presence Dnaaf1 and Dnaaf3, while Ktu assisted
weakly in the assembly of the light chains.
In conclusion, we have shown an essential role for Dyx1c1 (Dnaaf4), a
conserved dynein assembly factor in the pre-assembly of multiple ciliary
axonemal dyneins. Dyx1c1 function seems to be different from the other recently
identified PCD proteins Dnaaf1, Dnaaf2, Dnaaf3 and Mot4861 in that it is
essential for the assembly of the light chain and intermediate chain subunits (Fig.
5-5). We propose that Dyx1c1 assembles the intermediate chains in the
cytoplasm onto which the heavy chains get assembled. The light chains are
assembled in the cytoplasm in the presence of Dyx1c1, which are then
potentially targeted to the correct dynein subunit in the presence of other
assembly factors. In summary, Dyx1c1 defines a step in the multi-stage pathway
that is essential for the cytoplasmic assembly of the ciliary dyneins. Further
characterization of Dyx1c1 in the assembly process is required to determine
whether Dyx1c1 is involved in the chaperone-mediated folding of the individual
subunits, or their association into the multi-subunit dynein arm complex.
Because there are many dynein subunits and their isoforms that are required for
the normal ciliary function, and the current assembly factors do not contribute to
the formation of all the dynein complexes, there is a need for additional future
studies to identify more assembly factor proteins.
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Figure 5-5: Proposed role of Dyx1c1 in the cytoplasmic assembly pathway.
Dyx1c1 interacts with the chaperones and intermediate as well as light chain dynein
subunits in the cytoplasm. The heavy chains are added onto the intermediate chains
and the light chains are further incorporated into the outer dynein arm complex in the
presence of Dyx1c1 and other assembly factors.

5.5 Materials and Methods
5.5.1 Deciliation of the trachea
The tracheas harvested from postnatal day 16 (P16) Dyx1c1 wildtype and
knockout mice were washed with cold phosphate-buffered saline to remove
mucus and cell debris. Animal procedures were performed under protocols
approved by the Institutional Animal Care and Use Committee of the University of
Connecticut and conform to US NIH guidelines. The dissected tracheas were
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transferred to a separate tube containing deciliation buffer, and incubated for 10
min with intermittent mild vortexing. The supernatant was collected in a separate
tube, and the procedure was repeated twice. The tracheas were then separated
from the supernatant, the three washings were pooled, and after pelleting cell
debris at 800xg, the ciliary axonemes were collected by centrifugation at
20,000xg. Ciliary axonemal pellets were resuspended gently in 30 mM Hepes
(pH 7.3), 1 mM EGTA, 0.1 mM EDTA, 25 mM NaCl, 5 mM MgSO4, 1 mM
dithiothreitol, and 1% volume of protease inhibitor mixture (Sigma). Triton X-100
was added (0.5%) to the suspension, and the axonemes were incubated for 15
min on ice, followed by centrifugation. The lysates containing the axonemal
fraction were then frozen at -80°C. The cilia-stripped-tracheas were incubated in
RIPA buffer (Sigma) on ice for 20 min. Samples were homogenized using a
tissue homogenizer and cleared by centrifugation at 10,000g for 10 min to obtain
the protein lysate of the cytoplasmic fraction of the trachea. Protein
concentrations were estimated using the BCA reagent (Pierce).
5.5.2 Protein blots of whole trachea, cytoplasmic and axonemal lysates
For whole tracheal preparation, tracheal tissues were dissected from wildtype
and knockout mice, and carefully separated from the surrounding tissues. After
incubation in RIPA Buffer supplemented with 1× Protease Inhibitor Cocktail
(Sigma), samples were homogenized using a tissue homogenizer and cleared by
centrifugation at 10,000g for 10 min. The cytoplasmic and axonemal fractions of
the trachea were prepared as described above. Proteins were separated on 12%
SDS- PAGE minigels and then transferred to Immobilon (Millipore) membrane for
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protein blotting. For detecting DYX1C1 protein, the antibody to N-terminal
DYX1C1 (Sigma, SAB4200128) was used at a dilution of 1:200; antibody to
acetylated tubulin (Sigma, T6793) was used at a dilution of 1:2000; and antibody
to GAPDH (Sigma, G8795) was used at a 1:1,500 dilution as a loading control.
LI-COR Odyssey infrared secondary antibodies (goat antibody to mouse 680
(926-32220), goat antibody to mouse 800 (926-32210), goat antibody to rabbit
680 (926-32221) and goat antibody to rabbit 800 (926-32211)) were used at
dilutions of 1:15,000. All blots were imaged and analyzed using a LI-COR
Odyssey Scanner and Software.
5.5.3 Plasmids
To construct Dnal1 and Dnal4 expression plasmids, cDNAs of Dnal1 and Dnal4
respectively were amplified by PCR (Platinum Hi-Fidelity TaqDNA polymerase,
Invitrogen) from cDNA clones (BioSource). Dnal1 and Dnal4 sequences were
further amplified using primers incorporating flag and myc epitope tagged
sequences respectively and then subcloned into pCAG vector to create pCAGDnal1-flag and pCAG-Dnal4-myc plasmids. The GFP fused full length (pCAGDyx1c1-GFP) and deletion constructs of Dyx1c1 (pCAG-ΔTPR-GFP and pCAGΔp23-GFP) were constructed as described previously124. The pCAG-GFP
plasmid was used as a control. The flag-tagged DNAAF1, DNAAF2 and DNAAF3
plasmids were a gift from Dr. Heymut Omran. The sequence of all plasmids was
confirmed by sequencing.
5.5.4 Cell culture and transfection
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Human embryonic kidney (HEK293T) cells were grown to confluence in DMEM
supplemented with 10% FBS, 1% non-essential amino acid (NEAA) and 1%
penicillin-streptomycin antibiotics (Invitrogen). Cultures were plated at a density
of 106 cells on a 10-cm petridish. DNA (24 µg) was added to the petridish with 75
µl of Lipofectamine 2000 reagent (Invitrogen) in OptiMEM-1. The transfection mix
was added to cells in normal growth media and incubated for 48 h at 37 °C. To
obtain the protein lysates from the cells, the normal growth media was removed
and the cells were washed with PBS. The cells were then collected, centrifuged
to pellet the cells and the pellet was incubated in RIPA buffer supplemented with
1X Proteinase Inhibitor Cocktail for 20 min on ice. The lysates were then
centrifuged at 2000xg to pellet the debris. Protein blots were also performed on
the transfected cells as described above.
5.5.5 Immunoprecipitation
Immunoprecipitation assays were performed using the Dynabeads Protein G
Immunoprecipitation kit (Invitrogen). Briefly, Dynabeads were resuspended in the
vial and separated on a magnet from solution. Antibody to Dyx1c1 (Sigma,
SAB4200128), Dnal1 (Proteintech, 15809-1-AP), Dnal4 (Proteintech, 10388-1AP), DNAI2 (Abnova, M01, clone 1C8) or GFP (Life Technologies, A11122) (5
µg) was diluted in 200 µl of Washing and Binding Solution and incubated with
rotation for 120 min at room temperature. Bead-antibody complexes were
separated on the magnet, washed by gentle pipetting and separated. Protein
lysates were incubated with the bead-antibody complexes overnight at 4 °C.
Bead-antibody-antigen complexes were then washed using the washing solution
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three times. Complexes were then incubated with elution buffer for 10–15 min to
dissociate them. Beads were separated on a magnet, and supernatant containing
the proteins was separated by SDS-PAGE and analyzed by protein blotting using
monoclonal antibody to DNAI2 (Abnova, M01, clone 1C8; 1:500 dilution),
antibody to DNAI1 (Proteintech, 12756-1-AP; 1:500 dilution), antibody to Hsp70
(BD Biosciences, 610607; 1:1,000 dilution), antibody to Txndc3 (Proteintech,
13586-1-AP, 1:500), antibody to Hsp90 (BD Biosciences, 610418; 1:1,000
dilution), antibody to CCT4 (Aviva Systems Biology, ARP34271_P050; 1:500
dilution), antibody to CCT3 (Proteintech, 10571-1-AP; 1:500 dilution), anti- body
to CCT5 (Proteintech, 11603-1-AP; 1:500 dilution), antibody to CCT8
(Proteintech, 12263-1-AP; 1:500 dilution), c-myc antibody (Sigma, C3956, 1:500
dilution), c-myc antibody mouse monoclonal (Sigma, M4439, 1:750 dilution),
antibody to flag produced in rabbit (Sigma, SAB1306078, 1:1000 dilution), and
mouse monoclonal anti-flag antibody (Sigma, F4042, 1:500 dilution). Rabbit IgG
was used as a control.
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6. SUMMARY
This dissertation is focused on characterization of the developmental role of
Dyx1c1. In this chapter, I will summarize the significance of my results and
discuss the role of Dyx1c1 in the axonemal dynein preassembly process,
followed by a detailed discussion of the unanswered questions.

6.1 Summary of Chapters 2,3 and 4
In the present study, reverse genetics approach has been successfully applied to
assess the function of a candidate dyslexia gene Dyx1c1. We identified that
Dyx1c1 knockout mice generated by the deletion of exons 2, 3 and 4 of Dyx1c1
causes an absence of the Dyx1c1 protein. The mutation in Dyx1c1 in mice leads
to PCD-like symptoms of hydrocephalus and situs inversus. Investigation of the
mutant embryonic node revealed abnormalities as evident from the deposition of
vesicle-like structures on the nodal surface in addition to monocilia; indicative of
ciliary dysmotility. The ependymal cilia of the brain ventricles were examined by
videomicroscopy and Indian ink assay to find mutant cilia completely immotile.
Ultrastructural analysis of these mutant cilia further revealed the absence of two
components of the motile cilia critical for ciliary motility, outer and inner dynein
arms, missing from the mutant ciliary axoneme. Similar PCD-associated
phenotypes were found in the Dyx1c1 mouse mutant, zebrafish knockdown and
human PCD patients160. Thus, Dyx1c1 is an evolutionarily conserved protein
essential for the motility of cilia. This gene is speculated to be important for
formation of the outer and inner dynein arms in the cytoplasm, or their transport
and binding to the microtubules in the axoneme.
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Given the loss of identifiable IDA and ODA in Dyx1c1 mutant cilia, we analyzed
the subcellular localization of Dyx1c1 and observed that Dyx1c1 localized to
apical cytoplasm of the respiratory epithelial cells. These results led us to the
hypothesis that Dyx1c1 is required for the cytoplasmic pre-assembly of axonemal
dyneins. The Dyx1c1 mutation affected the localization of axonemal components
of motile cilia. No expression of ODA DNAI2 and DNAH5 was detected by
immunofluorescence in Dyx1c1 mutant cilia of the mice and PCD patients. To
obtain insights into Dyx1c1 function, we further defined the interactome of
Dyx1c1 by immunoprecipitation and mass spectrometric analysis. Endogenous
Dyx1c1 complexes were isolated by immunoprecipitation from wildtype tracheal
lysates and tandem MS/MS analysis was performed on the immunoprecipitates
to find that the Dyx1c1 interactome was enriched for the proteins in the
categories of chaperones and cytoskeletal proteins. Previously known interactors
of Dyx1c1 such as Hsp70 and Hsp90 were identified by MS screen. In addition, a
group of T-complex chaperones (CCTs), with a known role in ciliogenesis, were
also identified as interaction partners of Dyx1c1. Furthermore, Dyx1c1 interacted
with a protein of the transition zone, Sept2, known to mediate the control of
protein trafficking into and out of the ciliary axoneme. Immunoprecipitation and
immunoblot analysis confirmed the interaction of Dyx1c1 with these newly
identified interaction partners. The interactions were also validated in
heterologous expression system; and it was further demonstrated that the TPR
domains mediated the interaction of Dyx1c1 with the Hsp70 and CCTs, while the
p23 domain was sufficient for interaction with Hsp90.
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The cytoplasm of the ciliated cells supposedly accumulates the assembled
precursor ODA/IDA motor complex prior to its transport into the axoneme.
Information about the assembly state of the ODA/IDA in the Dyx1c1 mutant
would thus be apparent by analyzing the cytoplasmic extract of the mutant
cytoplasm. Hence we performed deciliation of the wildtype and knockout trachea
to obtain axonemal fraction and deciliated tracheal fraction and assessed the
cytoplasmic abundance of the dynein arm subunits. Western blot analysis with
antibodies against components of outer dynein arms (DNAI1, DNAI2, DNAL1,
DNAL4) and inner dynein arms (DNALI1) exhibited a reduction in the abundance
of these subunits in the knockout tracheal cytoplasmic fraction compared to the
wildtype. The decrease in the dynein subunits is suggestive of a faulty dynein
arm assembly in the cytoplasm due to either altered degradation of the
unassembled dynein subunits or decreased synthesis of the subunits. These
results suggested a role of Dyx1c1 in the chaperone-dependent assembly of the
dynein arms by assisting in the folding and stability of the individual dynein arm
subunits or aiding in the incorporation of the subunits into a functional motor
complex. Alternatively, the data suggest that Dyx1c1 might be required for the
stability of the assembled dynein motor complex and trafficking to the base of the
cilium at the transition zone.
A novel PCD-causing mutation in Dyx1c1 (p.L19Q) was recently identified in an
inbred Druze population of Israel. This mutation was identified in the p23 domain
of the Dyx1c1 protein and hence it was interesting to characterize this mutant
biochemically. The patients suffered from the above-mentioned classic PCD
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symptoms and lacked the expression of the ODA intermediate chain DNAI1 as
well as the IDA chain DNALI1 from the mutant axoneme. Immunoblot analysis of
the patient respiratory epithelial protein lysates demonstrated that the Dyx1c1
protein was expressed in the PCD patients at the correct size as were the
proteins Sept2 and Ktu. However, intriguingly the interaction of Dyx1c1 with
Setp2 and Ktu was reduced by more than half in the presence of the mutant
compared to the control condition. Additional analysis of the dynein subunit
abundance exhibited decreased expression of the ODA subunits DNAI2 and IDA
subunit DNALI1; indicative of a defective pre-assembly of the dynein arms, thus
strengthening our claim that Dyx1c1 is a cytoplasmic pre-assembly factor.
Outer arm dynein assembly is a multistep process that involves preassembly of
subunits in the cytoplasm, movement of complexes into flagella, and assembly of
these complexes into a functional dynein arm (Fig. 6-2).
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Figure 6-2: Schematic of the cytoplasmic pre-assembly of the outer dynein arm.
The outer dynein arm subunits are synthesized and transported to the base of the
cilium at the basal body region. These subunits are then assembled together into a
functional outer dynein arm in the presence of the chaperones and assembly factors.
The assembled complex is docked onto the IFT particles for their transport into the
axoneme and later attached to the microtubules. (Adapted from Fliegauf et al. 2008)

Most mutations that disrupt this process have been traced to genes encoding
subunits of the dynein motor itself, or cytoplasmic assembly factors of axonemal
dyneins, or subunits of complexes that form binding sites for motor attachment.
Cytoplasmic preassembly of dynein HCs has been found to require at least two
steps61. The first step involves the folding of the globular dynein head domain,
which is required for HC stability. DNAAF1 and DNAAF2 contribute to this step
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together with HSP70. The second step involves formation of the HC–IC complex,
which requires DNAAF3 (Fig. 6-3). Further experiments are needed to
understand the specific role of Dyx1c1 in the assembly process.

Figure 6-3: Schematic of the proposed outer dynein arm pre-assembly in the
presence of the cytoplasmic assembly factors. The heavy chains require the
action of DNAAF1, DNAAF2 and DNAAF3 for the proper folding of their head
domains and their stability. These assembly factors may also contribute to later steps
in which heavy chains associate with intermediate chains. We hypothesize that these
assembly factors work with a chaperone complex (labeled with a question mark).
(Adapted from Mitchison et al. 2012)

Our biochemical analyses provided important insight into the proposed function
of Dyx1c1 as a facilitator of dynein pre-assembly, by revealing defects in the
interaction of intermediate and light chains in the cytoplasm. Immunoprecipitation
experiments demonstrated an interaction between Dyx1c1 and the intermediate
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chains, Dnai1 and Dnai2 as well as the light chains Dnal1 and Dnal4 in the
cytoplasm of tracheal epithelial cells. Furthermore, the association of Dnai1 to
Dnai2 and Dnal1 to Dnal4 was reduced in the mutant tracheal cytoplasm
compared to the wildtype. The assembly of the intermediate to light chains was
also found to be disrupted in the mutant cytoplasm. Heterologous experiments in
transfected HEK cells showed that the light chains interacted with Dyx1c1 via the
TPR domains of Dyx1c1. Interestingly these domains are previously identified to
be important for Dyx1c1 role in neuronal migration as well as interaction with
Hsp70 and CCTs. When the interaction of the light chains Dnal1 and Dnal4 was
investigated, we found that Dyx1c1 was necessary to induce the interaction of
the light chains. Intriguingly, both the domains of Dyx1c1 were required for the
light chain association. Furthermore, the interaction of the light chains could be
induced partially in the presence of Ktu/DNAAF2 but with the other assembly
factors DNAAF1 or DNAAF3.

6.2 Cytoplasmic preassembly of axonemal dyneins
To understand the cytoplasmic preassembly process and specifically the role of
Dyx1c1 in it, the following questions need to be addressed.
6.2.1 Which ultrastructural components does Dyx1c1 localize to?
Cilia are complex organelles requiring the proper functioning of several proteins.
Electron microscopy has been useful in providing a detailed knowledge of the
ciliary ultra structure. It is necessary to comprehend the specific macromolecules
that contribute to the ciliary structures. Hence, to characterize the role of Dyx1c1
in the cytoplasmic preassembly in greater detail, it would be interesting to identify
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the subcellular structures that associate with Dyx1c1 to pinpoint the pathway of
Dyx1c1. Future studies performed using the immunoEM technique could assist
in analyzing the ultrastructural localization of Dyx1c1 in ciliated cells. It could be
speculated that since Dyx1c1 plays a role in the cytoplasmic preassembly of the
dyneins, it would be localized at the base of the cilia around the basal bodies.
Alternately, Dyx1c1 would be arranged almost linearly from the base of the cilia
to the transition zone suggesting a function of Dyx1c1 in dynein arm transport.
Studies have shown that Dyx1c1 interacts with chaperones and if Dyx1c1 were
to function in protein folding or quality control, immunoEM would be able to
detect its localization to the ER. The results obtained from these experiments will
help us understand the role of Dyx1c1 in cytoplasm.

6.2.2 Is Dyx1c1 necessary for folding/stability of dynein subunits?
Our results show that the axonemal dynein subunits are reduced from the
cytoplasm of the Dyx1c1 knockout trachea; thus indicating a role of Dyx1c1 in
folding and/or stability of the axonemal dyneins. To determine if Dyx1c1 plays a
role in the chaperone dependent assembly of the dynein arms, trypsin sensitivity
assays could be performed to examine the folding state of the dynein subunits in
the cytoplasm of the mutant. The abnormally folded chains would show an
increased sensitivity to tryptic proteolysis in the KO indicating that Dyx1c1
functions in chaperoning steps that aid in the folding of those subunits. Abnormal
protein folding leads to rapid degradation of the misfolded proteins, which would
lead to reduction in their abundance. If the subunits are misfolded and are getting
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depleted from the cytoplasmic pool due to higher rates of degradation, protein
turnover rates could be examined by blocking protein synthesis using
cycloheximide and probing for dynein subunit-specific antibodies.
6.2.3 Can Dyx1c1 re-expression rescue the ciliary immotility in the KO?
RNAi studies found that knockdown of Dyx1c1 caused abnormal cortical
migration in rat neocortex, while overexpression of full-length Dyx1c1 lead to the
rescue of the phenotype. Dyx1c1 deficiency leads to loss of ciliary motility and
therefore, overexpression of Dyx1c1 in KO ciliated cells will be interesting to
assess for the rescue of the immotility phenotype. The rescue experiments would
also provide important insights into the assembly state of the dynein arms thus
aiding in the understanding of the assembly process.

6.3 Dyx1c1 and ciliogenesis
Study in Chlamydomonas performed by our collaborators, identified an
upregulation of Dyx1c1 during flagellar regeneration. This indicates that Dyx1c1
might have a putative function during ciliary regeneration as well as cell stress. It
would be interesting to evaluate the differentially expressed genes and changes
in localization patterns of Dyx1c1 on wildtype and knockout ciliated epithelial
cells at various time points following stress-induced ciliary sloughing (deciliation).

6.4 Primary Ciliary Dyskinesia: Diagnosis and Treatment
Our knowledge of PCD has greatly increased with the genotype-phenotype
correlation being better understood and more information about diagnostic and
therapeutic options becoming available. In the future, it would be interesting to
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identify pharmacological targets that have the potential to assist in protein
expression and in turn overcome ciliary dysfunction. Another key issue is the
identification and confirmation of more PCD causing genes. Cilia and flagella
require many dynein isoforms for their normal function. The dynein assembly
factors studied to date do not seem to be responsible for the formation of all of
these axonemal dynein complexes. Future studies may identify additional
proteins that are involved in these cytoplasmic assembly steps. This knowledge
is crucial to allow for the development of suitable and effective screening
methods and therapeutic agents.

6.5 Final Remarks
This study emphasizes the importance of the cytoplasmic preassembly steps in
the formation of axonemal dynein arms. Based on the results presented here, the
cytoplasmic assembly of axonemal dynein motors requires at least three steps:
an earlier step required for chaperone-mediated folding of the axonemal dyneins,
next step of aggregating the intermediate and light chains of the axonemal
dyneins mediated by assembly factors and a later step that incorporates these
dynein chains to generate an assembly competent motor complex (Fig. 5-5). In
conclusion, we have shown an essential role for Dyx1c1 (DNAAF4), a conserved
dynein assembly factor, in the assembly of multiple ciliary axonemal dyneins.
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